Exempt Chemical Preparations Under the Controlled Substances Act, 38765-38770 [2021-15024]

Download as PDF Federal Register / Vol. 86, No. 138 / Thursday, July 22, 2021 / Notices programs, personnel, and operations of the Commission including under 5 U.S.C. appendix 3; or (ii) by U.S. government employees and contract personnel,2 solely for cybersecurity purposes. All nonconfidential written submissions will be available for public inspection at the Office of the Secretary and on EDIS.3 This action is taken under the authority of section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and of §§ 201.10 and 210.8(c) of the Commission’s Rules of Practice and Procedure (19 CFR 201.10, 210.8(c)). By order of the Commission. Issued: July 16, 2021. Katherine Hiner, Acting Secretary to the Commission. [FR Doc. 2021–15553 Filed 7–21–21; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–372] Exempt Chemical Preparations Under the Controlled Substances Act Drug Enforcement Administration, Department of Justice. ACTION: Order with opportunity for comment. lotter on DSK11XQN23PROD with NOTICES1 AGENCY: field on the web page or to attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon completion of your submission you will receive a Comment Tracking Number for your comment. Please be aware that submitted comments are not instantaneously available for public view on Regulations.gov. If you have received a comment tracking number, your comment has been successfully submitted and there is no need to resubmit the same comment. Paper comments: Paper comments that duplicate the electronic submission are not necessary and are discouraged. Should you wish to mail a comment in lieu of an electronic comment, it should be sent via regular or express mail to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. FOR FURTHER INFORMATION CONTACT: Terrence L. Boos, Ph.D., Diversion Control Division, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 362–8201. SUPPLEMENTARY INFORMATION: Posting of Public Comments Please note that all comments received are considered part of the public record and made available for SUMMARY: The applications for exempt public inspection online at https:// chemical preparations received by the www.regulations.gov and in the DEA’s Drug Enforcement Administration public docket. Such information (DEA) between September 1, 2020, and includes personal identifying March 31, 2021, as listed below, were information (such as your name, accepted for filing and have been address, etc.) voluntarily submitted by approved or denied as indicated. the commenter. The Freedom of DATES: Interested persons may file Information Act applies to all comments written comments on this order in received. accordance with 21 CFR 1308.23(e). If you want to submit personal Electronic comments must be identifying information (such as your submitted, and written comments must name, address, etc.) as part of your be postmarked, on or before September comment, but do not want it to be 20, 2021. Commenters should be aware posted online or made available in the that the electronic Federal Docket public docket, you must include the Management System will not accept comments after 11:59 p.m. Eastern Time phrase ‘‘PERSONAL IDENTIFYING INFORMATION’’ in the first paragraph on the last day of the comment period. of your comment. You must also place ADDRESSES: To ensure proper handling all the personal identifying information of comments, please reference ‘‘Docket you do not want posted online or made No. DEA–372’’ on all correspondence, available in the public docket in the first including any attachments. paragraph of your comment and identify Electronic comments: DEA encourages what information you want redacted. that all comments be submitted through If you want to submit confidential the Federal eRulemaking Portal, which business information as part of your provides the ability to type short comment, but do not want it to be comments directly into the comment posted online or made available in the public docket, you must include the 2 All contract personnel will sign appropriate phrase ‘‘CONFIDENTIAL BUSINESS nondisclosure agreements. INFORMATION’’ in the first paragraph 3 Electronic Document Information System (EDIS): https://edis.usitc.gov. of your comment. You must also VerDate Sep<11>2014 19:38 Jul 21, 2021 Jkt 253001 PO 00000 Frm 00091 Fmt 4703 Sfmt 4703 38765 prominently identify confidential business information to be redacted within the comment. Comments containing personal identifying information and confidential business information identified as directed above will generally be made publicly available in redacted form. If a comment has so much confidential business information that it cannot be effectively redacted, all or part of that comment may not be made publicly available. Comments posted to https:// www.regulations.gov may include any personal identifying information (such as name, address, and phone number) included in the text of your electronic submission that is not identified as directed above as confidential. An electronic copy of this document is available at https:// www.regulations.gov for easy reference. Legal Authority Section 201 of the Controlled Substances Act (CSA) (21 U.S.C. 811) authorizes the Attorney General, by regulation, to exempt from certain provisions of the CSA certain compounds, mixtures, or preparations containing a controlled substance, if he finds that such compounds, mixtures, or preparations meet the requirements detailed in 21 U.S.C. 811(g)(3)(B).1 DEA regulations at 21 CFR 1308.23 and 1308.24 further detail the criteria by which DEA’s Assistant Administrator may exempt a chemical preparation or mixture from certain provisions of the CSA. The Assistant Administrator may, pursuant to 21 CFR 1308.23(f), modify or revoke the criteria by which exemptions are granted and modify the scope of exemptions at any time. Exempt Chemical Preparation Applications Submitted Between September 1, 2020, and March 31, 2021 The Assistant Administrator received applications between September 1, 2020, and March 31, 2021, requesting exempt chemical preparation status detailed in 21 CFR 1308.23. Pursuant to the criteria stated in 21 U.S.C. 811(g)(3)(B) and in 21 CFR 1308.23, the Assistant Administrator has found that each of the compounds, mixtures, and preparations described in Chart I below is intended for laboratory, industrial, educational, or special research purposes and not for general administration to a human being or animal and either: (1) Contains no 1 This authority has been delegated from the Attorney General to the Administrator of the DEA by 28 CFR 0.100, and subsequently redelegated to the Deputy Assistant Administrator pursuant to 28 CFR 0.104 and Section 7 of the appendix to subpart R of part 0. E:\FR\FM\22JYN1.SGM 22JYN1 38766 Federal Register / Vol. 86, No. 138 / Thursday, July 22, 2021 / Notices narcotic controlled substance and is packaged in such a form or concentration that the packaged quantity does not present any significant potential for abuse; or (2) contains either a narcotic or nonnarcotic controlled substance and one or more adulterating or denaturing agents in such a manner, combination, quantity, proportion, or concentration that the preparation or mixture does not present any potential for abuse and, if the preparation or mixture contains a narcotic controlled substance, is formulated in such a manner that it incorporates methods of denaturing or other means so that the preparation or mixture is not liable to be abused or have ill effects, if abused, and so that the narcotic substance cannot in practice be removed. Accordingly, pursuant to 21 U.S.C. 811(g)(3)(B), 21 CFR 1308.23, and 21 CFR 1308.24, the Assistant Administrator has determined that each of the chemical preparations or mixtures generally described in Chart I below and specifically described in the application materials received by DEA is exempt, to the extent described in 21 CFR 1308.24, from application of sections 302, 303, 305, 306, 307, 308, 309, 1002, 1003, and 1004 (21 U.S.C. 822–823, 825–829, and 952–954) of the CSA, and 21 CFR 1301.74, as of the date that was provided in the approval letters to the individual requesters. Scope of Approval The exemptions are applicable only to the precise preparation or mixture described in the application submitted to DEA in the form(s) listed in this order and only for those above mentioned sections of the CSA and the CFR. In accordance with 21 CFR 1308.24(h), any change in the quantitative or qualitative composition of the preparation or mixture, or change in the trade name or other designation of the preparation or mixture after the date of application requires a new application. The requirements set forth in 21 CFR 1308.24(b)–(e) apply to the exempted materials. In accordance with 21 CFR 1308.24(g), DEA may prescribe requirements other than those set forth in 21 CFR 1308.24(b)–(e) on a case-bycase basis for materials exempted in bulk quantities. Accordingly, in order to limit opportunity for diversion from the larger bulk quantities, DEA has determined that each of the exempted bulk products listed in this order may only be used in-house by the manufacturer, and may not be distributed for any purpose, or transported to other facilities. Additional exempt chemical preparation requests received between September 1, 2020, and March 31, 2021, and not otherwise referenced in this order, may remain under consideration until DEA receives additional information required, pursuant to 21 CFR 1308.23(d), as detailed in separate correspondence to individual requesters. DEA’s order on such requests will be communicated to the public in a future Federal Register publication. DEA also notes that these exemptions are limited to exemption from only those sections of the CSA and the CFR that are specifically identified in 21 CFR 1308.24(a). All other requirements of the CSA and the CFR apply, including registration as an importer as required by 21 U.S.C. 957. lotter on DSK11XQN23PROD with NOTICES1 CHART I Application date Supplier Product name Form Aalto Scientific, Ltd ............................ Aalto Scientific, Ltd ............................ Aalto Scientific, Ltd ............................ Aalto Scientific, Ltd ............................ Aalto Scientific, Ltd ............................ Agilent Technologies ......................... Cambridge Isotope Laboratories, Inc Cambridge Isotopes Laboratories, Inc. Cambridge Isotopes Laboratories, Inc. Cambridge Isotopes Laboratories, Inc. Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cal Ver FLQ Drugs of Abuse for Roche Systems Level 1 ........................ Cal Ver FLQ Drugs of Abuse for Roche Systems Level 2 ........................ Cal Ver FLQ Drugs of Abuse for Roche Systems Level 3 ........................ Linearity FD Fertility Siemens Centaur ...................................................... Linearity FLQ TDM for Ortho Vitros ........................................................... Custom Organic Std—11 analytes at 250 μg/mL ...................................... Labeled Steroid Mix 40X Set S NSK-S-40X .............................................. Delta-9-tetrahydrocannabinol (THC) Unlabeled (95% CP), 1000 μg/mL in methanol (0.1%). Delta-9-Trans-tetrahydrocannabinol (THC) (Methyl-D3, 98%), 100 μg/mL in methanol (0.01%). Testosterone (2,3,4-13C3, 99%) 100 μg/mL in acetonitrile ....................... Glass vial: 3 mL ............................... Glass vial: 3 mL ............................... Glass vial: 3 mL ............................... Kit: 10 vials; 3 mL each ................... Kit: 5 dropper bottles; 4 mL each .... Amber ampule: 1 mL ....................... Glass vial: 1 mL ............................... Glass ampule: 1.2 mL ...................... 2/23/2021 2/23/2021 2/23/2021 3/29/2021 3/31/2021 2/19/2021 3/1/2021 2/19/2021 Glass ampule: 1.2 mL ...................... 2/19/2021 Glass ampule: 1 mL ......................... 2/19/2021 Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass Glass 1 mL ......................... 1 mL ......................... 1 mL ......................... 1 mL ......................... 1 mL ......................... 1 mL ......................... 1 mL ......................... 1 mL ......................... 1 mL ......................... 1 mL ......................... 1 mL ......................... 1 mL ......................... 1 mL ......................... 1 mL ......................... 1 mL ......................... 1 mL ......................... 1 mL ......................... 1 mL ......................... 1 mL ......................... 1 mL ......................... 1 mL ......................... 1 mL ......................... 1 mL ......................... 1 mL ......................... 0.5 mL ...................... 2/3/2021 2/3/2021 2/3/2021 2/3/2021 2/23/2021 2/23/2021 2/23/2021 2/23/2021 2/23/2021 2/23/2021 2/3/2021 2/3/2021 2/3/2021 2/3/2021 2/3/2021 2/3/2021 2/3/2021 2/3/2021 2/23/2021 2/23/2021 2/23/2021 2/23/2021 2/23/2021 2/23/2021 2/23/2021 Glass ampule: 0.5 mL ...................... 2/3/2021 Glass ampule: 0.5 mL ...................... 2/23/2021 Cayman Chemical Company ............ Cayman Chemical Company ............ VerDate Sep<11>2014 17:10 Jul 21, 2021 (+/¥)-11-hydroxy-d8-THC (CRM) 1 mg/ml, 1 mL in acetonitrile ............... (+/¥)-11-hydroxy-d8-THC (CRM) 1 mg/ml, 1 mL in methanol ................. (+/¥)-11-hydroxy-d8-THC (CRM) 100 μg/mL, 1 mL in acetonitrile ........... (+/¥)-11-hydroxy-d8-THC (CRM) 100 μg/mL, 1 mL in methanol ............. Benzoylecgonine (CRM) 1 mg/mL, 1 mL in methanol ............................... Benzoylecgonine (CRM) 100 μg/mL, 1 mL in methanol ............................ Benzoylecgonine-d3 (CRM) 1 mg/mL, 1 mL in methanol .......................... Benzoylecgonine-d3 (CRM) 100 μg/mL, 1 mL in methanol ....................... Cocaine-d3 (CRM) 1 mg/mL, 1 mL in acetonitrile ..................................... Cocaine-d3 (CRM) 100 μg/mL, 1 mL in acetonitrile .................................. D8-THCB (CRM) 100 μg/mL, 1 mL acetonitrile ......................................... D8-THCB (CRM) 1 mg/ml, 1 mL in acetonitrile ......................................... D8-THCB (CRM) 1 mg/ml, 1 mL methanol ................................................ D8-THCB (CRM) 100 μg/mL, 1 mL methanol ............................................ D8-THCP (CRM) 1 mg/ml, 1 mL in acetonitrile ......................................... D8-THCP (CRM) 1 mg/ml, 1 mL methanol ................................................ D8-THCP (CRM) 100 μg/mL, 1 mL acetonitrile ......................................... D8-THCP (CRM) 100 μg/mL, 1 mL methanol ............................................ D9-THC Acetate (CRM) 1 mg/mL, 1 mL in acetonitrile ............................. D9-THC Acetate (CRM) 1 mg/mL, 1 mL in methanol ................................ D9-THC Acetate (CRM) 100 μg/mL, 1 mL in acetonitrile .......................... D9-THC Acetate (CRM) 100 μg/mL, 1 mL in methanol ............................. Norfentanyl-d5 (CRM) 1 mg/mL, 1 mL in methanol ................................... Norfentanyl-d5 (CRM) 100 μg/mL, 1 mL in methanol ................................ Phytocannabinoid Acids Mixture 5 (CRM) 100 μg/mL 0.5 mL in 1:99 DIPEA: acetonitrile with 0.05% ascorbic acid. Phytocannabinoid Acids Mixture 5 (CRM) 100 μg/mL 0.5 mL in acetonitrile. Phytocannabinoid Acids Mixture 6 (CRM) 1 mg/mL 0.5 mL in 1:99 DIPEA: acetonitrile with 0.05% ascorbic acid. Jkt 253001 PO 00000 Frm 00092 Fmt 4703 Sfmt 4703 E:\FR\FM\22JYN1.SGM ampule: ampule: ampule: ampule: ampule: ampule: ampule: ampule: ampule: ampule: ampule: ampule: ampule: ampule: ampule: ampule: ampule: ampule: ampule: ampule: ampule: ampule: ampule: ampule: ampule: 22JYN1 Federal Register / Vol. 86, No. 138 / Thursday, July 22, 2021 / Notices 38767 CHART I—Continued Product name Form Cayman Chemical Company ............ Cayman Chemical Company ............ Phytocannabinoid Acids Mixture 6 (CRM) 1 mg/mL 0.5 mL in acetonitrile Phytocannabinoid Acids Mixture 6 (CRM) 1 mg/mL 1 mL in 1:99 DIPEA: acetonitrile with 0.05% ascorbic acid. Phytocannabinoid Acids Mixture 6 (CRM) 1 mg/mL 1 mL in acetonitrile .. Phytocannabinoid Acids Mixture 6 (CRM) 100 μg/mL 1 mL in 1:99 DIPEA: acetonitrile with 0.05% ascorbic acid. Phytocannabinoid Acids Mixture 6 (CRM) 100 μg/mL 1 mL in acetonitrile Phytocannabinoid Acids Mixture 6 (CRM) 250 μg/mL 0.5 mL in 1:99 DIPEA: acetonitrile with 0.05% ascorbic acid. Phytocannabinoid Acids Mixture 6 (CRM) 250 μg/mL 0.5 mL in acetonitrile. Phytocannabinoid Acids Mixture 6 (CRM) 250 μg/mL 1 mL in 1:99 DIPEA: acetonitrile with 0.05% ascorbic acid. Phytocannabinoid Acids Mixture 6 (CRM) 250 μg/mL 1 mL in acetonitrile Phytocannabinoid Acids Mixture 6 (CRM) 500 μg/mL 0.5 mL in 1:99 DIPEA: acetonitrile with 0.05% ascorbic acid. Phytocannabinoid Acids Mixture 6 (CRM) 500 μg/mL 0.5 mL in acetonitrile. Phytocannabinoid Acids Mixture 6 (CRM) 500 μg/mL 1 mL in 1:99 DIPEA: acetonitrile with 0.05% ascorbic acid. Phytocannabinoid Acids Mixture 6 (CRM) 500 μg/mL 1 mL in acetonitrile Phytocannabinoid Acids Mixture 7 (CRM) 1 mg/mL 0.5 mL in 1:99 DIPEA: acetonitrile with 0.05% ascorbic acid. Phytocannabinoid Acids Mixture 7 (CRM) 1 mg/mL 0.5 mL in acetonitrile Phytocannabinoid Acids Mixture 7 (CRM) 1 mg/mL, 1 mL in 1:99 DIPEA: acetonitrile with 0.05% ascorbic acid. Phytocannabinoid Acids Mixture 7 (CRM) 1 mg/mL, 1 mL in acetonitrile Phytocannabinoid Acids Mixture 7 (CRM) 100 μg/mL 0.5 mL in 1:99 DIPEA: acetonitrile with 0.05% ascorbic acid. Phytocannabinoid Acids Mixture 7 (CRM) 100 μg/mL 0.5 mL in acetonitrile. Phytocannabinoid Acids Mixture 7 (CRM) 100 μg/mL, 1 mL in 1:99 DIPEA: acetonitrile with 0.05% ascorbic acid. Phytocannabinoid Acids Mixture 7 (CRM) 100 μg/mL, 1 mL in acetonitrile. Phytocannabinoid Acids Mixture 7 (CRM) 250 μg/mL 0.5 mL in 1:99 DIPEA: acetonitrile with 0.05% ascorbic acid. Phytocannabinoid Acids Mixture 7 (CRM) 250 μg/mL 0.5 mL in acetonitrile. Phytocannabinoid Acids Mixture 7 (CRM) 250 μg/mL, 1 mL in 1:99 DIPEA: acetonitrile with 0.05% ascorbic acid. Phytocannabinoid Acids Mixture 7 (CRM) 250 μg/mL, 1 mL in acetonitrile. Phytocannabinoid Acids Mixture 7 (CRM) 500 μg/mL, 1 mL in 1:99 DIPEA: acetonitrile with 0.05% ascorbic acid. Phytocannabinoid Acids Mixture 7 (CRM) 500 μg/mL, 1 mL in acetonitrile. Phytocannabinoid Acids Mixture 7 (CRM) 500 μg/mL 0.5 mL in 1:99 DIPEA: acetonitrile with 0.05% ascorbic acid. Phytocannabinoid Acids Mixture 7 (CRM) 500 μg/mL 0.5 mL in acetonitrile. Psilocin (CRM) 1 mg/mL in Acetonitrile ..................................................... Psilocin (CRM) 100 μg/mL in Acetonitrile .................................................. Psilocin-d10 (CRM) 1 mg/mL in Acetonitrile .............................................. Psilocin-d10 (CRM) 100 μg/mL in Acetonitrile ........................................... Psilocin-d4 (CRM) 1 mg/mL in Acetonitrile ................................................ Psilocin-d4 (CRM) 100 μg/mL in Acetonitrile ............................................. Psilocybin (CRM) 1 mg/mL in 1:1 Acetonitrile:H2O ................................... Psilocybin (CRM) 100 μg/mL in 1:1 Acetonitrile:H2O ................................ Psilocybin-d10 (CRM) 1 mg/mL in 1:1 Acetonitrile:H2O ............................ Psilocybin-d10 (CRM) 100 μg/mL in 1:1 Acetonitrile:H2O ......................... Psilocybin-d4 (CRM) 1 mg/mL in 1:1 Acetonitrile:H2O .............................. Psilocybin-d4 (CRM) 100 μg/mL in 1:1 Acetonitrile:H2O ........................... U-47700 (CRM) 1 mg/mL, 1 mL in methanol ............................................ U-47700 (CRM) 100 μg/mL, 1 mL in methanol ......................................... U-47700-d6 (CRM) 1 mg/mL, 1 mL in methanol ....................................... U-47700-d6 (CRM) 100 μg/mL, 1 mL in methanol .................................... (¥)-delta8-THC-D3 .................................................................................... 4-Methyl-alpha-pyrrolidinobutiophenone HCl (MPBP HCl) (1.0 mg/mL) ... Tetrahydrocannabivarin-D5 (THCV-D5) ..................................................... Tetrahydrocannabivarinic acid-D5 (THCVA-D5) ........................................ AMP/6-AM Oral Fluid Calibrator 1 ............................................................. AMP/6-AM Oral Fluid Calibrator 2 ............................................................. AMP/6-AM Oral Fluid Calibrator 3 ............................................................. AMP/6-AM Oral Fluid Calibrator 4 ............................................................. AMP/6-AM Oral Fluid Set ........................................................................... Cannabinoids Acid/Neutrals Mixture 202 Kit 250 μg/mL in Acetonitrile .... Cannabinoids Acid/Neutrals Mixture 203 Kit 500 μg/mL in Acetonitrile .... Cannabinoids Acid/Neutrals Mixture 204 Kit 1000 μg/mL in Acetonitrile .. Cannabinoids Acid/Neutrals Mixture 205 Kit 250 μg/mL in Acetonitrile .... Glass ampule: 0.5 mL ...................... Glass ampule: 1 mL ......................... 2/3/2021 2/23/2021 Glass ampule: 1 mL ......................... Glass ampule: 1 mL ......................... 2/3/2021 2/23/2021 Glass ampule: 1 mL ......................... Glass ampule: 0.5 mL ...................... 2/3/2021 2/23/2021 Glass ampule: 0.5 mL ...................... 2/3/2021 Glass ampule: 1 mL ......................... 2/23/2021 Glass ampule: 1 mL ......................... Glass ampule: 0.5 mL ...................... 2/3/2021 2/23/2021 Glass ampule: 0.5 mL ...................... 2/3/2021 Glass ampule: 1 mL ......................... 2/23/2021 Glass ampule: 1 mL ......................... Glass ampule: 0.5 mL ...................... 2/3/2021 2/23/2021 Glass ampule: 0.5 mL ...................... Glass ampule: 1 mL ......................... 2/3/2021 2/23/2021 Glass ampule: 1 mL ......................... Glass ampule: 0.5 mL ...................... 2/3/2021 2/23/2021 Glass ampule: 0.5 mL ...................... 2/3/2021 Glass ampule: 1 mL ......................... 2/23/2021 Glass ampule: 1 mL ......................... 2/3/2021 Glass ampule: 0.5 mL ...................... 2/23/2021 Glass ampule: 0.5 mL ...................... 2/3/2021 Glass ampule: 1 mL ......................... 2/23/2021 Glass ampule: 1 mL ......................... 2/3/2021 Glass ampule: 1 mL ......................... 2/23/2021 Glass ampule: 1 mL ......................... 2/3/2021 Glass ampule: 0.5 mL ...................... 2/23/2021 Glass ampule: 0.5 mL ...................... 2/3/2021 Glass ampule: 1.0 mL ...................... Glass ampule: 0.5 mL ...................... Glass ampule: 1.0 mL ...................... Glass ampule: 1.0 mL ...................... Glass ampule: 1.0 mL ...................... Glass ampule: 1.0 mL ...................... Glass ampule: 1.0 mL ...................... Glass ampule: 0.5 mL ...................... Glass ampule: 1.0 mL ...................... Glass ampule: 1.0 mL ...................... Glass ampule: 0.5 mL ...................... Glass ampule: 0.5 mL ...................... Glass ampule: 1 mL ......................... Glass ampule: 1 mL ......................... Glass ampule: 1 mL ......................... Glass ampule: 1 mL ......................... Glass ampule: 1 mL ......................... Glass ampule: 1 mL ......................... Glass ampule: 1 mL ......................... Glass ampule: 1 mL ......................... Amber vial: 10 mL ............................ Amber vial: 10 mL ............................ Amber vial: 10 mL ............................ Amber vial: 10 mL ............................ Kit: 2 vials, 10 mL each ................... 1 kit: 2 vials × 0.4 mL ...................... 1 kit: 2 vials × 0.4 mL ...................... 1 kit: 2 vials × 0.4 mL ...................... 1 kit: 2 vials × 0.4 mL ...................... 2/24/2021 2/24/2021 2/24/2021 2/24/2021 2/24/2021 2/24/2021 2/24/2021 2/24/2021 2/24/2021 2/24/2021 2/24/2021 2/24/2021 2/23/2021 2/23/2021 2/23/2021 2/23/2021 1/26/2021 3/4/2021 1/26/2021 1/26/2021 2/10/2021 2/10/2021 2/10/2021 2/10/2021 2/10/2021 3/19/2021 3/19/2021 3/19/2021 3/19/2021 Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ lotter on DSK11XQN23PROD with NOTICES1 Application date Supplier Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cayman Chemical Company ............ Cerilliant Corporation ......................... Cerilliant Corporation ......................... Cerilliant Corporation ......................... Cerilliant Corporation ......................... Immunalysis Corporation ................... Immunalysis Corporation ................... Immunalysis Corporation ................... Immunalysis Corporation ................... Immunalysis Corporation ................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... VerDate Sep<11>2014 17:10 Jul 21, 2021 Jkt 253001 PO 00000 Frm 00093 Fmt 4703 Sfmt 4703 E:\FR\FM\22JYN1.SGM 22JYN1 38768 Federal Register / Vol. 86, No. 138 / Thursday, July 22, 2021 / Notices CHART I—Continued Product name Form LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... LGC—Dr. Ehrenstorfer ...................... o2si smart solutions .......................... o2si smart solutions .......................... Cannabinoids Acid/Neutrals Mixture 206 Kit 500 μg/mL in Acetonitrile .... Cannabinoids Acid/Neutrals Mixture 207 Kit 1000 μg/mL in Acetonitrile .. Cannabinoids Acid/Neutrals Mixture 214 Kit 250 μg/mL in Acetonitrile .... Cannabinoids Acid/Neutrals Mixture 214 Kit 250 μg/mL in Acetonitrile .... Cannabinoids Acid/Neutrals Mixture 215 Kit 500 μg/mL in Acetonitrile .... Cannabinoids Acid/Neutrals Mixture 215 Kit 500 μg/mL in Acetonitrile .... Cannabinoids Acid/Neutrals Mixture 216 Kit 1000 μg/mL in Acetonitrile .. Cannabinoids Acid/Neutrals Mixture 216 Kit 1000 μg/mL in Acetonitrile .. Cannabinoids Acid/Neutrals Mixture 250 Kit 1000 μg/mL in Acetonitrile .. Cannabinoids Acid/Neutrals Mixture 250 Kit 1000 μg/mL in Acetonitrile .. Cannabinoids Acids Mixture 184 1000 μg/mL in Acetonitrile .................... Cannabinoids Acids Mixture 185 500 μg/mL in Acetonitrile ...................... Cannabinoids Acids Mixture 186 250 μg/mL in Acetonitrile ...................... Cannabinoids Acids Mixture 194 250 μg/mL in Acetonitrile ...................... Cannabinoids Acids Mixture 195 500 μg/mL in Acetonitrile ...................... Cannabinoids Acids Mixture 200 1000 μg/mL in Acetonitrile .................... Cannabinoids Acids Mixture 210 250 μg/mL in Acetonitrile ...................... Cannabinoids Acids Mixture 210 250 μg/mL in Acetonitrile ...................... Cannabinoids Acids Mixture 211 500 μg/mL in Acetonitrile ...................... Cannabinoids Acids Mixture 211 500 μg/mL in Acetonitrile ...................... Cannabinoids Acids Mixture 212 1000 μg/mL in Acetonitrile .................... Cannabinoids Acids Mixture 212 1000 μg/mL in Acetonitrile .................... Cannabinoids Mixture 187 100 μg/mL in Acetonitrile ................................ Cannabinoids Mixture 188 500 μg/mL in Acetonitrile ................................ Cannabinoids Mixture 189 1000 μg/mL in Acetonitrile .............................. Cannabinoids Mixture 190 50 μg/mL in Acetonitrile .................................. Cannabinoids Mixture 191 100 μg/mL in Acetonitrile ................................ Cannabinoids Mixture 192 500 μg/mL in Acetonitrile ................................ Cannabinoids Mixture 193 1000 μg/mL in Acetonitrile .............................. Cannabinoids Mixture 197 500 μg/mL in Acetonitrile ................................ Cannabinoids Mixture 198 500 μg/mL in Acetonitrile ................................ Cannabinoids Mixture 213 500 μg/mL in Acetonitrile ................................ Cannabinoids Mixture 254 250 μg/mL in Acetonitrile ................................ Cannabinoids Mixture 254 250 μg/mL in Acetonitrile ................................ Cannabinoids Mixture 255 500 μg/mL in Acetonitrile ................................ Cannabinoids Mixture 255 500 μg/mL in Acetonitrile ................................ Cannabinoids Mixture 256 250 μg/mL in Acetonitrile ................................ Cannabinoids Mixture 256 250 μg/mL in Acetonitrile ................................ Cannabinoids Mixture 257 500 μg/mL in Acetonitrile ................................ Cannabinoids Mixture 257 500 μg/mL in Acetonitrile ................................ Cannabinoids Mixture 258 Kit 250 μg/mL in Acetonitrile ........................... Cannabinoids Mixture 258 Kit 250 μg/mL in Acetonitrile ........................... Cannabinoids Mixture 259 Kit 500 μg/mL in Acetonitrile ........................... Cannabinoids Mixture 259 Kit 500 μg/mL in Acetonitrile ........................... Custom D9-Tetrahydrocannabivarin (THCV) 1000 ug/mL in Acetonitrile .. D9-Tetrahydrocannabivarinic acid (THCVA) 100 ug/mL in Acetonitrile ..... Chloral Hydrate 1000 μg/mL in methanol .................................................. Custom Pharmaceutical Mixture CCV 16–0260, 10.0 μg/mL, 300 μL with a 2 mL silanized vial (ISO17034). Custom Pharmaceutical Mixture ICV (second source), 16–0260, 10.0 μg/ mL, 300 μL with a 2 mL silanized vial (ISO17034). Custom Pharmaceutical Mixture Level #1, 16–0260, 0.3 μg/mL, 300 μL with a 2 mL silanized vial (ISO17034). Custom Pharmaceutical Mixture Level #2, 16–0260, 1.0 μg/mL, 300 μL with a 2 mL silanized vial (ISO17034). Custom Pharmaceutical Mixture Level #3, 16–0260, 5.0 μg/mL, 300 μL with a 2 mL silanized vial (ISO17034). Custom Pharmaceutical Mixture Level #4, 16–0260, 10.0 μg/mL, 300 μL with a 2 mL silanized vial (ISO17034). Custom Pharmaceutical Mixture Level #5, 16–0260, 25.0 μg/mL, 300 μL with a 2 mL silanized vial (ISO17034). Custom Pharmaceutical Mixture Level #6, 16–0260, 50.0 μg/mL, 300 μL with a 2 mL silanized vial (ISO17034). Custom Pharmaceutical Mixture Level #7, 16–0260, 100.0 μg/mL, 300 μL with a 2 mL silanized vial (ISO17034). Custom Pharmaceutical Mixture Level #8, 16–0260, 250.0 μg/mL, 300 μL with a 2 mL silanized vial (ISO17034). Custom Pharmaceutical Mixture Calibration Kit 16–0260, (2 × G34– 140260–98). Custom Pharmaceutical Mixture Calibration Pack 16–0260, 13 × 1 ml .... Custom Pharmaceutical Mixture LCS, 16–0260, 10.0 ug/mL, 1 mL with a 2 ml Silanized Vial (ISO17034). 0584, 7232, 6089, 8785, 7227, 8588, 7541, 4336, 1817, 0737, 5340, 2985, 8470, 3501, 7362, 6850, 5497, 4097, 2479, 1536, 7431, 9541, 1585, 8534, 2113, 9789, 2482, 1013, 1483, 8092, 6365, 2209, 5434, 4035, 9222, 9674, 5622, 3806, 1798, 9820. 3370, 1411, 5883, 5713, 8800, 3630, 8683, 4541, 8161, 0359, 9704, 2184, 0341, 2901, 0790, 6548, 3466, 0352, 5288, 8594, 0279, 8762, 3687, 2819, 8743, 7197, 5064, 0199, 1609, 8643, 6467, 2245, 0706, 0147, 6876, 3732, 9314, 1059, 8245, 8685. 1 kit: 2 vials × 0.4 mL ...................... 1 kit: 2 vials × 0.4 mL ...................... 1 kit: 2 vials × 0.4 mL ...................... 1 Kit: 2 vials × 0.4 mL ...................... 1 kit: 2 vials × 0.4 mL ...................... 1 Kit: 2 vials × 0.4 mL ...................... 1 kit: 2 vials × 0.4 mL ...................... 1 Kit: 2 vials × 0.4 mL ...................... 1 kit: 2 vials × 0.4 mL ...................... 1 Kit: 2 vials × 0.4 mL ...................... Amber ampule: 0.4 mL .................... Amber ampule: 0.4 mL .................... Amber ampule: 0.4 mL .................... Amber ampule: 0.4 mL .................... Amber ampule: 0.4 mL .................... Amber ampule: 0.4 mL .................... Amber ampule: 0.4 mL .................... Amber ampule: 0.4 mL .................... Amber ampule: 0.4 mL .................... Amber ampule: 0.4 mL .................... Amber ampule: 0.4 mL .................... Amber ampule: 0.4 mL .................... Amber ampule: 0.4 mL .................... Amber ampule: 0.4 mL .................... Amber ampule: 0.4 mL .................... Amber ampule: 0.4 mL .................... Amber ampule: 0.4 mL .................... Amber ampule: 0.4 mL .................... Amber ampule: 0.4 mL .................... Amber ampule: 0.4 mL .................... Amber ampule: 0.4 mL .................... Amber ampule: 0.4 mL .................... Amber ampule: 0.4 mL .................... Amber ampule: 0.4 mL .................... Amber ampule: 0.4 mL .................... Amber ampule: 0.4 mL .................... Amber ampule: 0.4 mL .................... Amber ampule: 0.4 mL .................... Amber ampule: 0.4 mL .................... Amber ampule: 0.4 mL .................... 1 kit: 2 vials × 0.4 mL ...................... 1 Kit: 2 vials × 0.4 mL ...................... 1 kit: 2 vials × 0.4 mL ...................... 1 Kit: 2 vials × 0.4 mL ...................... Amber ampule: 1 mL ....................... Amber ampule: 1 mL ....................... Amber ampule: 1 mL ....................... Amber ampule: 300 μL .................... 3/19/2021 3/19/2021 3/19/2021 10/9/2020 3/19/2021 10/9/2020 3/19/2021 10/9/2020 3/19/2021 10/9/2020 3/19/2021 3/19/2021 3/19/2021 3/19/2021 3/19/2021 3/19/2021 3/19/2021 10/9/2020 3/19/2021 10/9/2020 3/19/2021 10/9/2020 3/19/2021 3/19/2021 3/19/2021 3/19/2021 3/19/2021 3/19/2021 3/19/2021 3/19/2021 3/19/2021 3/19/2021 3/19/2021 10/9/2020 3/19/2021 10/9/2020 3/19/2021 3/10/2021 3/19/2021 3/10/2021 3/31/2021 3/10/2021 3/19/2021 3/10/2021 1/19/2021 3/10/2021 3/24/2021 3/1/2021 Amber ampule: 300 μL .................... 3/1/2021 Amber ampule: 300 μL .................... 3/1/2021 Amber ampule: 300 μL .................... 3/1/2021 Amber ampule: 300 μL .................... 3/1/2021 Amber ampule: 300 μL .................... 3/1/2021 Amber ampule: 300 μL .................... 3/1/2021 Amber ampule: 300 μL .................... 3/1/2021 Amber ampule: 300 μL .................... 3/1/2021 Amber ampule: 300 μL .................... 3/1/2021 1 kit; 26 amber ampules × 300 μL .. 3/1/2021 1 pack; 13 amber ampules × 300 μL Amber ampule: 1 mL ....................... 3/1/2021 3/1/2021 HDPE tubes: 5 mL ........................... 3/11/2021 HDPE tubes: 5 mL ........................... 3/11/2021 o2si smart solutions .......................... o2si smart solutions .......................... o2si smart solutions .......................... o2si smart solutions .......................... o2si smart solutions .......................... o2si smart solutions .......................... o2si smart solutions .......................... o2si smart solutions .......................... o2si smart solutions .......................... o2si smart solutions .......................... o2si smart solutions .......................... o2si smart solutions .......................... lotter on DSK11XQN23PROD with NOTICES1 Application date Supplier Research Triangle Institute ............... Research Triangle Institute ............... VerDate Sep<11>2014 17:10 Jul 21, 2021 Jkt 253001 PO 00000 Frm 00094 Fmt 4703 Sfmt 4703 E:\FR\FM\22JYN1.SGM 22JYN1 Federal Register / Vol. 86, No. 138 / Thursday, July 22, 2021 / Notices 38769 CHART I—Continued Product name Form Research Triangle Institute ............... 4118, 3472, 9120, 3742, 9323, 4475, 5116, 7455, 3780, 9052, 4910, 2630, 6141, 9351, 5220, 2730, 6408, 3560, 4063, 0427, 0669, 8350, 9163, 6359, 0113, 1893, 4552, 2951, 1357, 8372, 9203, 3150, 9587, 9290, 4399, 2454, 2468, 7560, 6645, 8756. 4761, 2869, 4267, 9207, 1568, 8723, 7042, 6810, 0605, 7181, 8624, 0015, 5050, 7046, 3626, 7515, 9023, 8821, 6767, 0861, 0689, 5934, 2105, 2006, 1040, 5645, 2749, 7908, 9154, 8450, 5251, 6608, 3152, 9027, 2731, 7530, 1329, 0320, 5833, 7580. 4946, 2135, 7589, 456, 2617, 2224, 5066, 4134, 9514, 0206, 2691, 2807, 1571, 2201, 0943, 6995, 1299, 3729, 9561, 2552, 1248, 7138, 1634, 0813, 6352, 3567, 2017, 6701, 6915, 4448, 1967, 3179, 2480, 5144, 8826, 5515, 0949, 6109, 4040, 8632. 6673, 1920, 9080, 9040, 1769, 9824, 8015, 4813, 1535, 4285, 5824, 7430, 3338, 2989, 2743, 1537, 6009, 4808, 0243, 7097, 5533, 6638, 3414, 8238, 2573, 6806, 3959, 7896, 3448, 5652, 5273, 1341, 1063, 6664, 9471, 7136, 3571, 8916, 8617, 8946. 7155, 9763, 5721, 5161, 0009, 8118, 7420, 0527, 4415, 6892, 6896, 8988, 6477, 9903, 6688, 0292, 9380, 4579, 9601, 7337, 1518, 2189, 8886, 8880, 6963, 9446, 7721, 9988, 7688, 2525, 4017, 6826, 3426, 4128, 6270, 4207, 0646, 5741, 6086, 0528. 7938, 8287, 2990, 7693, 6858, 5995, 1929, 3740, 4461, 0196, 4271, 9853, 5024, 6378, 3409, 2702, 7629, 6194, 4553, 2871, 0203, 4812, 7073, 0834, 2732, 1841, 9545, 5063, 5062, 6234, 0210, 9740, 9472, 9938, 5122, 8677, 3537, 5198, 5977, 8203. 8497, 8384, 3406, 0324, 6930, 3165, 1564, 8858, 4968, 8840, 7836, 9412, 9009, 0109, 0695, 0923, 0912, 3228, 6855, 5103, 8580, 4499, 8347, 7831, 8420, 2875, 6778, 6680, 9098, 1987, 6813, 6572, 9943, 6165, 0958, 5884, 1843, 2991, 3191, 1151. 9493, 8564, 6768, 1670, 2733, 0560, 7822, 7495, 1290, 4534, 6583, 3937, 6596, 2599, 9164, 5702, 8328, 9643, 5747, 1923, 0976, 3416, 1445, 3834, 3069, 7609, 6580, 3945, 1726, 2891, 4325, 8970, 7248, 1981, 3906, 0989, 3648, 7769, 4122, 9050. Cannabinoids Acids 7 Standard ................................................................. AED II MR Serum Control .......................................................................... Amphetamines Panel Level 1 Urine Control .............................................. Amphetamines Panel Level 2 Urine Control .............................................. Benzodiazepines Hydrolysis QC Urine Control ......................................... Benzodiazepines Plus 100 ng/mL Urine Control ....................................... Benzodiazepines Plus 100 ng/mL Whole Blood Control ........................... Benzodiazepines Plus 400 ng/mL Urine Control ....................................... DAU IA 1 Urine Control .............................................................................. DAU IA 2 Urine Control .............................................................................. DAU IA 3 Urine Control .............................................................................. DAU IA 4 Urine Control .............................................................................. DAU IA 5 Urine Control .............................................................................. DHEA Plus High Serum Control ................................................................ DHEA Plus Low Serum Control ................................................................. Drugs of Abuse 200% Cutoff SMX Oral Fluid Control ............................... Drugs of Abuse 50% Cutoff SMX Oral Fluid Control ................................. Drugs of Abuse Cutoff SMX Oral Fluid Control ......................................... Drugs of Abuse Level 2 Whole Blood Control ........................................... Miscellaneous Panel Level 1 Urine Control ............................................... Miscellaneous Panel Level 2 Urine Control ............................................... Opiates Hydrolysis QC Urine Control ........................................................ Pentobarbital Serum Control ...................................................................... STABBS Negative Serum Control .............................................................. STABBS Positive Serum Control ............................................................... Steroids Level 1 SMX Serum Control ........................................................ Steroids Level 2 SMX Serum Control ........................................................ Steroids Level 3 SMX Serum Control ........................................................ Steroids Level 4 SMX Serum Control ........................................................ Tapentadol Hydrolysis QC Urine Control ................................................... Urine Drug Screen Urine Control ............................................................... Z Drugs Plus Level 1 Urine Control ........................................................... Z Drugs Plus Level 2 Urine Control ........................................................... Supplemented XVIVO Heart Solution (SXHS) ........................................... XVIVO Heart Perfusion System (XHPS) .................................................... HDPE tubes: 5 mL ........................... 3/11/2021 HDPE tubes: 5 mL ........................... 3/11/2021 HDPE tubes: 5 mL ........................... 3/11/2021 HDPE tubes: 5 mL ........................... 3/11/2021 HDPE tubes: 5 mL ........................... 3/11/2021 HDPE tubes: 5 mL ........................... 3/11/2021 HDPE tubes: 5 mL ........................... 3/11/2021 HDPE tubes: 5 mL ........................... 3/11/2021 Glass ampule: 1.3 mL ...................... Kit: 5 bottles, 5 mL each .................. Kit: 5 bottles, 5 mL each .................. Kit: 5 bottles, 5 mL each .................. Kit: 5 bottles, 3 mL each .................. Kit: 5 bottles, 5 mL each .................. Kit: 5 bottles, 5 mL each .................. Kit: 5 bottles, 5 mL each .................. Kit: 4 bottles, 10 mL each ................ Kit: 4 bottles, 10 mL each ................ Kit: 4 bottles, 10 mL each ................ Kit: 4 bottles, 10 mL each ................ Kit: 4 bottles, 10 mL each ................ Kit: 5 bottles, 3 mL each .................. Kit: 5 bottles, 3 mL each .................. Kit: 5 bottles, 3 mL each .................. Kit: 5 bottles, 3 mL each .................. Kit: 5 bottles, 3 mL each .................. Kit: 5 bottles, 5 mL each .................. Kit: 5 bottles, 5 mL each .................. Kit: 5 bottles, 5 mL each .................. Kit: 5 bottles, 3 mL each .................. Kit: 5 bottles, 5 mL each .................. Kit: 5 bottles, 5 mL each .................. Kit: 5 bottles, 5 mL each .................. Kit: 5 bottles, 3 mL each .................. Kit: 5 bottles, 3 mL each .................. Kit: 5 bottles, 3 mL each .................. Kit: 5 bottles, 3 mL each .................. Kit: 5 bottles, 3 mL each .................. Kit: 5 bottles, 10 mL each ................ Kit: 5 bottles, 3 mL each .................. Kit: 5 bottles, 3 mL each .................. Glass vial: 10 mL ............................. Kit: Heart Box, Disposable, Supplemented Soln. 3/31/2021 11/20/2020 11/20/2020 11/20/2020 11/20/2020 11/20/2020 11/20/2020 11/20/2020 11/20/2020 11/20/2020 11/20/2020 11/20/2020 11/20/2020 11/20/2020 11/20/2020 11/20/2020 11/20/2020 11/20/2020 11/20/2020 11/20/2020 11/20/2020 11/20/2020 11/20/2020 11/20/2020 11/20/2020 11/20/2020 11/20/2020 11/20/2020 11/20/2020 11/20/2020 11/20/2020 11/20/2020 11/20/2020 9/11/2020 9/11/2020 Research Triangle Institute ............... Research Triangle Institute ............... Research Triangle Institute ............... Research Triangle Institute ............... Research Triangle Institute ............... Research Triangle Institute ............... Research Triangle Institute ............... Restek Corporation ........................... UTAK Laboratories, Inc ..................... UTAK Laboratories, Inc ..................... UTAK Laboratories, Inc ..................... UTAK Laboratories, Inc ..................... UTAK Laboratories, Inc ..................... UTAK Laboratories, Inc ..................... UTAK Laboratories, Inc ..................... UTAK Laboratories, Inc ..................... UTAK Laboratories, Inc ..................... UTAK Laboratories, Inc ..................... UTAK Laboratories, Inc ..................... UTAK Laboratories, Inc ..................... UTAK Laboratories, Inc ..................... UTAK Laboratories, Inc ..................... UTAK Laboratories, Inc ..................... UTAK Laboratories, Inc ..................... UTAK Laboratories, Inc ..................... UTAK Laboratories, Inc ..................... UTAK Laboratories, Inc ..................... UTAK Laboratories, Inc ..................... UTAK Laboratories, Inc ..................... UTAK Laboratories, Inc ..................... UTAK Laboratories, Inc ..................... UTAK Laboratories, Inc ..................... UTAK Laboratories, Inc ..................... UTAK Laboratories, Inc ..................... UTAK Laboratories, Inc ..................... UTAK Laboratories, Inc ..................... UTAK Laboratories, Inc ..................... UTAK Laboratories, Inc ..................... UTAK Laboratories, Inc ..................... UTAK Laboratories, Inc ..................... Xvivo Perfusion ................................. Xvivo Perfusion ................................. lotter on DSK11XQN23PROD with NOTICES1 Application date Supplier The Assistant Administrator has found that each of the compounds, mixtures, and preparations described in Chart II below is not consistent with the criteria stated in 21 U.S.C. 811(g)(3)(B) and in 21 CFR 1308.23. Accordingly, the VerDate Sep<11>2014 17:10 Jul 21, 2021 Jkt 253001 Assistant Administrator has determined that the chemical preparations or mixtures generally described in Chart II below and specifically described in the application materials received by DEA, are not exempt from application of any PO 00000 Frm 00095 Fmt 4703 Sfmt 4703 part of the CSA or from application of any part of the CFR, with regard to the requested exemption pursuant to 21 CFR 1308.23, as of the date that was provided in the determination letters to the individual requesters. E:\FR\FM\22JYN1.SGM 22JYN1 38770 Federal Register / Vol. 86, No. 138 / Thursday, July 22, 2021 / Notices CHART II Product name Form Cambridge Isotopes Laboratories, Inc. Cambridge Isotopes Laboratories, Inc. Cambridge Isotopes Laboratories, Inc. Cambridge Isotopes Laboratories, Inc. Cambridge Isotopes Laboratories, Inc. Cambridge Isotopes Laboratories, Inc. Cambridge Isotopes Laboratories, Inc. Cambridge Isotopes Laboratories, Inc. Cayman Chemical Company ............ LGC—Dr. Ehrenstorher ..................... Delta-9-tetrahydrocannabinol (THC) unlabeled (Chemical Purity 95%), 5 mg. Delta-9-tetrahydrocannabinol (THC) unlabeled (Chemical Purity 95%), 0.5 mg. Delta-9-tetrahydrocannabinol (THC) unlabeled (Chemical Purity 95%), 1 mg. Delta-9-tetrahydrocannabinol (THC) unlabeled (Chemical Purity 95%), 10 mg. Delta-9-Trans-tetrahydrocannabinol (THC) (Methyl-D3, 98%), 5 mg ........ Glass ampule: 5 mg ......................... 2/19/2021 Glass ampule: 0.5 mg ...................... 2/19/2021 Glass ampule: 1 mg ......................... 2/19/2021 Glass ampule: 10 mg ....................... 2/19/2021 Glass ampule: 5 mg ......................... 2/19/2021 Delta-9-Trans-tetrahydrocannabinol (THC) (Methyl-D3, 98%), 0.5 mg ..... Glass ampule: 0.5 mg ...................... 2/19/2021 Delta-9-Trans-tetrahydrocannabinol (THC) (Methyl-D3, 98%), 1 mg ........ Glass ampule: 1 mg ......................... 2/19/2021 Delta-9-Trans-tetrahydrocannabinol (THC) (Methyl-D3, 98%), 10 mg ...... Glass ampule: 10 mg ....................... 2/19/2021 Clonazepam (CRM) 1 mg/mL, 1 mL in acetonitrile ................................... D9-Tetrahydrocannabivarin 10,000 mg/L Parent stock in Methanol—NOT FOR SALE. Delta-9-THC 10000 μg/mL in Methanol ..................................................... Glass ampule: 1 mL ......................... Boston Round, Amber glass: 14 mL 2/23/2021 1/19/2021 Amber ampule: 2 mL ....................... 2/16/2021 LGC—Dr. Ehrenstorfer ...................... Opportunity for Comment DEPARTMENT OF JUSTICE Pursuant to 21 CFR 1308.23(e), any interested person may submit written comments on or objections to any chemical preparation in this order that has been approved or denied as exempt. If any comments or objections raise significant issues regarding any finding of fact or conclusion of law upon which this order is based, the Assistant Administrator will immediately suspend the effectiveness of any applicable part of this order until he may reconsider the application in light of the comments and objections filed. Thereafter, the Assistant Administrator shall reinstate, revoke, or amend his original order as he determines appropriate. Parole Commission Approved Exempt Chemical Preparations Are Posted on the DEA’s Website A list of all current exemptions, including those listed in this order, is available on the DEA’s website at https:// www.DEAdiversion.usdoj.gov/ schedules/exempt/exempt_chemlist.pdf. The dates of applications of all current exemptions are posted for easy reference. William T. McDermott, Assistant Administrator. [FR Doc. 2021–15024 Filed 7–21–21; 8:45 am] BILLING CODE 4410–09–P lotter on DSK11XQN23PROD with NOTICES1 Application date Supplier SECURITIES AND EXCHANGE COMMISSION [Investment Company Act Release No. 34333; 812–15219] Sunshine Act Meeting Record of Vote of Meeting Closure Capital Southwest Corporation, et al.; Notice of Application (Public Law 94–409) (5 U.S.C. Sec. 552b) July 16, 2021. I, Patricia K. Cushwa, Acting Chairman of the United States Parole Commission, was present at a meeting of said Commission, which started at approximately 2:30 p.m., on Tuesday, July 13, 2021, at the U.S. Parole Commission, 90 K Street NE, Third Floor, Washington, DC 20530. The purpose of the meeting was to discuss an original jurisdiction case pursuant to 28 CFR 2.25. and 28 CFR 2.68(i)(1) Two Commissioners were present, constituting a quorum when the vote to close the meeting was submitted. Public announcement further describing the subject matter of the meeting and certifications of the General Counsel that this meeting may be closed by votes of the Commissioners present were submitted to the Commissioners prior to the conduct of any other business. Upon motion duly made, seconded, and carried, the following Commissioners voted that the meeting be closed: Patricia K. Cushwa and Charles T. Massarone. In witness whereof, I make this official record of the vote taken to close this meeting and authorize this record to be made available to the public. Patricia K. Cushwa, Acting Chairman, U.S. Parole Commission. [FR Doc. 2021–15788 Filed 7–20–21; 4:15 pm] BILLING CODE 4410–31–P VerDate Sep<11>2014 17:10 Jul 21, 2021 Jkt 253001 PO 00000 Frm 00096 Fmt 4703 Sfmt 4703 Securities and Exchange Commission (‘‘Commission’’). ACTION: Notice. AGENCY: Notice of an application for an order under section 6(c) of the Investment Company Act of 1940 (the ‘‘Act’’) for an exemption from sections 18(a) and 61(a) of the Act. APPLICANTS: Capital Southwest Corporation (the ‘‘Company’’), Capital Southwest SBIC I, LP (the ‘‘Capital Southwest SBIC’’), and Capital Southwest SBIC I GP, LLC (the ‘‘SBIC GP’’). SUMMARY OF THE APPLICATION: The Company requests an order to permit it to adhere to a modified asset coverage requirement. FILING DATES: The application was filed on April 21, 2021, and amended on July 14, 2021. HEARING OR NOTIFICATION OF HEARING: An order granting the requested relief will be issued unless the Commission orders a hearing. Interested persons may request a hearing by emailing the Commission’s Secretary at SecretarysOffice@sec.gov and serving applicants with a copy of the request by email. Hearing requests should be received by the Commission by 5:30 p.m. on August 10, 2021, and should be accompanied by proof of service on applicants, in the form of an affidavit or, for lawyers, a certificate of service. Pursuant to rule 0– E:\FR\FM\22JYN1.SGM 22JYN1

Agencies

[Federal Register Volume 86, Number 138 (Thursday, July 22, 2021)]
[Notices]
[Pages 38765-38770]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-15024]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-372]


Exempt Chemical Preparations Under the Controlled Substances Act

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: Order with opportunity for comment.

-----------------------------------------------------------------------

SUMMARY: The applications for exempt chemical preparations received by 
the Drug Enforcement Administration (DEA) between September 1, 2020, 
and March 31, 2021, as listed below, were accepted for filing and have 
been approved or denied as indicated.

DATES: Interested persons may file written comments on this order in 
accordance with 21 CFR 1308.23(e). Electronic comments must be 
submitted, and written comments must be postmarked, on or before 
September 20, 2021. Commenters should be aware that the electronic 
Federal Docket Management System will not accept comments after 11:59 
p.m. Eastern Time on the last day of the comment period.

ADDRESSES: To ensure proper handling of comments, please reference 
``Docket No. DEA-372'' on all correspondence, including any 
attachments.
    Electronic comments: DEA encourages that all comments be submitted 
through the Federal eRulemaking Portal, which provides the ability to 
type short comments directly into the comment field on the web page or 
to attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for 
submitting comments. Upon completion of your submission you will 
receive a Comment Tracking Number for your comment. Please be aware 
that submitted comments are not instantaneously available for public 
view on Regulations.gov. If you have received a comment tracking 
number, your comment has been successfully submitted and there is no 
need to resubmit the same comment.
    Paper comments: Paper comments that duplicate the electronic 
submission are not necessary and are discouraged. Should you wish to 
mail a comment in lieu of an electronic comment, it should be sent via 
regular or express mail to: Drug Enforcement Administration, Attention: 
DEA Federal Register Representative/DRW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

FOR FURTHER INFORMATION CONTACT: Terrence L. Boos, Ph.D., Diversion 
Control Division, Drug Enforcement Administration; Mailing Address: 
8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 
362-8201.

SUPPLEMENTARY INFORMATION:

Posting of Public Comments

    Please note that all comments received are considered part of the 
public record and made available for public inspection online at https://www.regulations.gov and in the DEA's public docket. Such information 
includes personal identifying information (such as your name, address, 
etc.) voluntarily submitted by the commenter. The Freedom of 
Information Act applies to all comments received.
    If you want to submit personal identifying information (such as 
your name, address, etc.) as part of your comment, but do not want it 
to be posted online or made available in the public docket, you must 
include the phrase ``PERSONAL IDENTIFYING INFORMATION'' in the first 
paragraph of your comment. You must also place all the personal 
identifying information you do not want posted online or made available 
in the public docket in the first paragraph of your comment and 
identify what information you want redacted.
    If you want to submit confidential business information as part of 
your comment, but do not want it to be posted online or made available 
in the public docket, you must include the phrase ``CONFIDENTIAL 
BUSINESS INFORMATION'' in the first paragraph of your comment. You must 
also prominently identify confidential business information to be 
redacted within the comment.
    Comments containing personal identifying information and 
confidential business information identified as directed above will 
generally be made publicly available in redacted form. If a comment has 
so much confidential business information that it cannot be effectively 
redacted, all or part of that comment may not be made publicly 
available. Comments posted to https://www.regulations.gov may include 
any personal identifying information (such as name, address, and phone 
number) included in the text of your electronic submission that is not 
identified as directed above as confidential.
    An electronic copy of this document is available at https://www.regulations.gov for easy reference.

Legal Authority

    Section 201 of the Controlled Substances Act (CSA) (21 U.S.C. 811) 
authorizes the Attorney General, by regulation, to exempt from certain 
provisions of the CSA certain compounds, mixtures, or preparations 
containing a controlled substance, if he finds that such compounds, 
mixtures, or preparations meet the requirements detailed in 21 U.S.C. 
811(g)(3)(B).\1\ DEA regulations at 21 CFR 1308.23 and 1308.24 further 
detail the criteria by which DEA's Assistant Administrator may exempt a 
chemical preparation or mixture from certain provisions of the CSA. The 
Assistant Administrator may, pursuant to 21 CFR 1308.23(f), modify or 
revoke the criteria by which exemptions are granted and modify the 
scope of exemptions at any time.
---------------------------------------------------------------------------

    \1\ This authority has been delegated from the Attorney General 
to the Administrator of the DEA by 28 CFR 0.100, and subsequently 
redelegated to the Deputy Assistant Administrator pursuant to 28 CFR 
0.104 and Section 7 of the appendix to subpart R of part 0.
---------------------------------------------------------------------------

Exempt Chemical Preparation Applications Submitted Between September 1, 
2020, and March 31, 2021

    The Assistant Administrator received applications between September 
1, 2020, and March 31, 2021, requesting exempt chemical preparation 
status detailed in 21 CFR 1308.23. Pursuant to the criteria stated in 
21 U.S.C. 811(g)(3)(B) and in 21 CFR 1308.23, the Assistant 
Administrator has found that each of the compounds, mixtures, and 
preparations described in Chart I below is intended for laboratory, 
industrial, educational, or special research purposes and not for 
general administration to a human being or animal and either: (1) 
Contains no

[[Page 38766]]

narcotic controlled substance and is packaged in such a form or 
concentration that the packaged quantity does not present any 
significant potential for abuse; or (2) contains either a narcotic or 
non-narcotic controlled substance and one or more adulterating or 
denaturing agents in such a manner, combination, quantity, proportion, 
or concentration that the preparation or mixture does not present any 
potential for abuse and, if the preparation or mixture contains a 
narcotic controlled substance, is formulated in such a manner that it 
incorporates methods of denaturing or other means so that the 
preparation or mixture is not liable to be abused or have ill effects, 
if abused, and so that the narcotic substance cannot in practice be 
removed.
    Accordingly, pursuant to 21 U.S.C. 811(g)(3)(B), 21 CFR 1308.23, 
and 21 CFR 1308.24, the Assistant Administrator has determined that 
each of the chemical preparations or mixtures generally described in 
Chart I below and specifically described in the application materials 
received by DEA is exempt, to the extent described in 21 CFR 1308.24, 
from application of sections 302, 303, 305, 306, 307, 308, 309, 1002, 
1003, and 1004 (21 U.S.C. 822-823, 825-829, and 952-954) of the CSA, 
and 21 CFR 1301.74, as of the date that was provided in the approval 
letters to the individual requesters.

Scope of Approval

    The exemptions are applicable only to the precise preparation or 
mixture described in the application submitted to DEA in the form(s) 
listed in this order and only for those above mentioned sections of the 
CSA and the CFR. In accordance with 21 CFR 1308.24(h), any change in 
the quantitative or qualitative composition of the preparation or 
mixture, or change in the trade name or other designation of the 
preparation or mixture after the date of application requires a new 
application. The requirements set forth in 21 CFR 1308.24(b)-(e) apply 
to the exempted materials. In accordance with 21 CFR 1308.24(g), DEA 
may prescribe requirements other than those set forth in 21 CFR 
1308.24(b)-(e) on a case-by-case basis for materials exempted in bulk 
quantities. Accordingly, in order to limit opportunity for diversion 
from the larger bulk quantities, DEA has determined that each of the 
exempted bulk products listed in this order may only be used in-house 
by the manufacturer, and may not be distributed for any purpose, or 
transported to other facilities.
    Additional exempt chemical preparation requests received between 
September 1, 2020, and March 31, 2021, and not otherwise referenced in 
this order, may remain under consideration until DEA receives 
additional information required, pursuant to 21 CFR 1308.23(d), as 
detailed in separate correspondence to individual requesters. DEA's 
order on such requests will be communicated to the public in a future 
Federal Register publication.
    DEA also notes that these exemptions are limited to exemption from 
only those sections of the CSA and the CFR that are specifically 
identified in 21 CFR 1308.24(a). All other requirements of the CSA and 
the CFR apply, including registration as an importer as required by 21 
U.S.C. 957.

                                                     Chart I
----------------------------------------------------------------------------------------------------------------
                                                                                                     Application
                Supplier                           Product name                      Form                date
----------------------------------------------------------------------------------------------------------------
Aalto Scientific, Ltd..................  Cal Ver FLQ Drugs of Abuse for   Glass vial: 3 mL.........    2/23/2021
                                          Roche Systems Level 1.
Aalto Scientific, Ltd..................  Cal Ver FLQ Drugs of Abuse for   Glass vial: 3 mL.........    2/23/2021
                                          Roche Systems Level 2.
Aalto Scientific, Ltd..................  Cal Ver FLQ Drugs of Abuse for   Glass vial: 3 mL.........    2/23/2021
                                          Roche Systems Level 3.
Aalto Scientific, Ltd..................  Linearity FD Fertility Siemens   Kit: 10 vials; 3 mL each.    3/29/2021
                                          Centaur.
Aalto Scientific, Ltd..................  Linearity FLQ TDM for Ortho      Kit: 5 dropper bottles; 4    3/31/2021
                                          Vitros.                          mL each.
Agilent Technologies...................  Custom Organic Std--11 analytes  Amber ampule: 1 mL.......    2/19/2021
                                          at 250 [micro]g/mL.
Cambridge Isotope Laboratories, Inc....  Labeled Steroid Mix 40X Set S    Glass vial: 1 mL.........     3/1/2021
                                          NSK-S-40X.
Cambridge Isotopes Laboratories, Inc...  Delta-9-tetrahydrocannabinol     Glass ampule: 1.2 mL.....    2/19/2021
                                          (THC) Unlabeled (95% CP), 1000
                                          [micro]g/mL in methanol (0.1%).
Cambridge Isotopes Laboratories, Inc...  Delta-9-Trans-                   Glass ampule: 1.2 mL.....    2/19/2021
                                          tetrahydrocannabinol (THC)
                                          (Methyl-D3, 98%), 100 [micro]g/
                                          mL in methanol (0.01%).
Cambridge Isotopes Laboratories, Inc...  Testosterone (2,3,4-13C3, 99%)   Glass ampule: 1 mL.......    2/19/2021
                                          100 [micro]g/mL in
                                          acetonitrile.
Cayman Chemical Company................  (+/-)-11-hydroxy-d8-THC (CRM) 1  Glass ampule: 1 mL.......     2/3/2021
                                          mg/ml, 1 mL in acetonitrile.
Cayman Chemical Company................  (+/-)-11-hydroxy-d8-THC (CRM) 1  Glass ampule: 1 mL.......     2/3/2021
                                          mg/ml, 1 mL in methanol.
Cayman Chemical Company................  (+/-)-11-hydroxy-d8-THC (CRM)    Glass ampule: 1 mL.......     2/3/2021
                                          100 [micro]g/mL, 1 mL in
                                          acetonitrile.
Cayman Chemical Company................  (+/-)-11-hydroxy-d8-THC (CRM)    Glass ampule: 1 mL.......     2/3/2021
                                          100 [micro]g/mL, 1 mL in
                                          methanol.
Cayman Chemical Company................  Benzoylecgonine (CRM) 1 mg/mL,   Glass ampule: 1 mL.......    2/23/2021
                                          1 mL in methanol.
Cayman Chemical Company................  Benzoylecgonine (CRM) 100        Glass ampule: 1 mL.......    2/23/2021
                                          [micro]g/mL, 1 mL in methanol.
Cayman Chemical Company................  Benzoylecgonine-d3 (CRM) 1 mg/   Glass ampule: 1 mL.......    2/23/2021
                                          mL, 1 mL in methanol.
Cayman Chemical Company................  Benzoylecgonine-d3 (CRM) 100     Glass ampule: 1 mL.......    2/23/2021
                                          [micro]g/mL, 1 mL in methanol.
Cayman Chemical Company................  Cocaine-d3 (CRM) 1 mg/mL, 1 mL   Glass ampule: 1 mL.......    2/23/2021
                                          in acetonitrile.
Cayman Chemical Company................  Cocaine-d3 (CRM) 100 [micro]g/   Glass ampule: 1 mL.......    2/23/2021
                                          mL, 1 mL in acetonitrile.
Cayman Chemical Company................  D8-THCB (CRM) 100 [micro]g/mL,   Glass ampule: 1 mL.......     2/3/2021
                                          1 mL acetonitrile.
Cayman Chemical Company................  D8-THCB (CRM) 1 mg/ml, 1 mL in   Glass ampule: 1 mL.......     2/3/2021
                                          acetonitrile.
Cayman Chemical Company................  D8-THCB (CRM) 1 mg/ml, 1 mL      Glass ampule: 1 mL.......     2/3/2021
                                          methanol.
Cayman Chemical Company................  D8-THCB (CRM) 100 [micro]g/mL,   Glass ampule: 1 mL.......     2/3/2021
                                          1 mL methanol.
Cayman Chemical Company................  D8-THCP (CRM) 1 mg/ml, 1 mL in   Glass ampule: 1 mL.......     2/3/2021
                                          acetonitrile.
Cayman Chemical Company................  D8-THCP (CRM) 1 mg/ml, 1 mL      Glass ampule: 1 mL.......     2/3/2021
                                          methanol.
Cayman Chemical Company................  D8-THCP (CRM) 100 [micro]g/mL,   Glass ampule: 1 mL.......     2/3/2021
                                          1 mL acetonitrile.
Cayman Chemical Company................  D8-THCP (CRM) 100 [micro]g/mL,   Glass ampule: 1 mL.......     2/3/2021
                                          1 mL methanol.
Cayman Chemical Company................  D9-THC Acetate (CRM) 1 mg/mL, 1  Glass ampule: 1 mL.......    2/23/2021
                                          mL in acetonitrile.
Cayman Chemical Company................  D9-THC Acetate (CRM) 1 mg/mL, 1  Glass ampule: 1 mL.......    2/23/2021
                                          mL in methanol.
Cayman Chemical Company................  D9-THC Acetate (CRM) 100         Glass ampule: 1 mL.......    2/23/2021
                                          [micro]g/mL, 1 mL in
                                          acetonitrile.
Cayman Chemical Company................  D9-THC Acetate (CRM) 100         Glass ampule: 1 mL.......    2/23/2021
                                          [micro]g/mL, 1 mL in methanol.
Cayman Chemical Company................  Norfentanyl-d5 (CRM) 1 mg/mL, 1  Glass ampule: 1 mL.......    2/23/2021
                                          mL in methanol.
Cayman Chemical Company................  Norfentanyl-d5 (CRM) 100         Glass ampule: 1 mL.......    2/23/2021
                                          [micro]g/mL, 1 mL in methanol.
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 0.5 mL.....    2/23/2021
                                          5 (CRM) 100 [micro]g/mL 0.5 mL
                                          in 1:99 DIPEA: acetonitrile
                                          with 0.05% ascorbic acid.
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 0.5 mL.....     2/3/2021
                                          5 (CRM) 100 [micro]g/mL 0.5 mL
                                          in acetonitrile.
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 0.5 mL.....    2/23/2021
                                          6 (CRM) 1 mg/mL 0.5 mL in 1:99
                                          DIPEA: acetonitrile with 0.05%
                                          ascorbic acid.

[[Page 38767]]

 
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 0.5 mL.....     2/3/2021
                                          6 (CRM) 1 mg/mL 0.5 mL in
                                          acetonitrile.
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 1 mL.......    2/23/2021
                                          6 (CRM) 1 mg/mL 1 mL in 1:99
                                          DIPEA: acetonitrile with 0.05%
                                          ascorbic acid.
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 1 mL.......     2/3/2021
                                          6 (CRM) 1 mg/mL 1 mL in
                                          acetonitrile.
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 1 mL.......    2/23/2021
                                          6 (CRM) 100 [micro]g/mL 1 mL
                                          in 1:99 DIPEA: acetonitrile
                                          with 0.05% ascorbic acid.
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 1 mL.......     2/3/2021
                                          6 (CRM) 100 [micro]g/mL 1 mL
                                          in acetonitrile.
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 0.5 mL.....    2/23/2021
                                          6 (CRM) 250 [micro]g/mL 0.5 mL
                                          in 1:99 DIPEA: acetonitrile
                                          with 0.05% ascorbic acid.
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 0.5 mL.....     2/3/2021
                                          6 (CRM) 250 [micro]g/mL 0.5 mL
                                          in acetonitrile.
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 1 mL.......    2/23/2021
                                          6 (CRM) 250 [micro]g/mL 1 mL
                                          in 1:99 DIPEA: acetonitrile
                                          with 0.05% ascorbic acid.
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 1 mL.......     2/3/2021
                                          6 (CRM) 250 [micro]g/mL 1 mL
                                          in acetonitrile.
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 0.5 mL.....    2/23/2021
                                          6 (CRM) 500 [micro]g/mL 0.5 mL
                                          in 1:99 DIPEA: acetonitrile
                                          with 0.05% ascorbic acid.
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 0.5 mL.....     2/3/2021
                                          6 (CRM) 500 [micro]g/mL 0.5 mL
                                          in acetonitrile.
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 1 mL.......    2/23/2021
                                          6 (CRM) 500 [micro]g/mL 1 mL
                                          in 1:99 DIPEA: acetonitrile
                                          with 0.05% ascorbic acid.
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 1 mL.......     2/3/2021
                                          6 (CRM) 500 [micro]g/mL 1 mL
                                          in acetonitrile.
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 0.5 mL.....    2/23/2021
                                          7 (CRM) 1 mg/mL 0.5 mL in 1:99
                                          DIPEA: acetonitrile with 0.05%
                                          ascorbic acid.
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 0.5 mL.....     2/3/2021
                                          7 (CRM) 1 mg/mL 0.5 mL in
                                          acetonitrile.
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 1 mL.......    2/23/2021
                                          7 (CRM) 1 mg/mL, 1 mL in 1:99
                                          DIPEA: acetonitrile with 0.05%
                                          ascorbic acid.
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 1 mL.......     2/3/2021
                                          7 (CRM) 1 mg/mL, 1 mL in
                                          acetonitrile.
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 0.5 mL.....    2/23/2021
                                          7 (CRM) 100 [micro]g/mL 0.5 mL
                                          in 1:99 DIPEA: acetonitrile
                                          with 0.05% ascorbic acid.
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 0.5 mL.....     2/3/2021
                                          7 (CRM) 100 [micro]g/mL 0.5 mL
                                          in acetonitrile.
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 1 mL.......    2/23/2021
                                          7 (CRM) 100 [micro]g/mL, 1 mL
                                          in 1:99 DIPEA: acetonitrile
                                          with 0.05% ascorbic acid.
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 1 mL.......     2/3/2021
                                          7 (CRM) 100 [micro]g/mL, 1 mL
                                          in acetonitrile.
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 0.5 mL.....    2/23/2021
                                          7 (CRM) 250 [micro]g/mL 0.5 mL
                                          in 1:99 DIPEA: acetonitrile
                                          with 0.05% ascorbic acid.
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 0.5 mL.....     2/3/2021
                                          7 (CRM) 250 [micro]g/mL 0.5 mL
                                          in acetonitrile.
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 1 mL.......    2/23/2021
                                          7 (CRM) 250 [micro]g/mL, 1 mL
                                          in 1:99 DIPEA: acetonitrile
                                          with 0.05% ascorbic acid.
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 1 mL.......     2/3/2021
                                          7 (CRM) 250 [micro]g/mL, 1 mL
                                          in acetonitrile.
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 1 mL.......    2/23/2021
                                          7 (CRM) 500 [micro]g/mL, 1 mL
                                          in 1:99 DIPEA: acetonitrile
                                          with 0.05% ascorbic acid.
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 1 mL.......     2/3/2021
                                          7 (CRM) 500 [micro]g/mL, 1 mL
                                          in acetonitrile.
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 0.5 mL.....    2/23/2021
                                          7 (CRM) 500 [micro]g/mL 0.5 mL
                                          in 1:99 DIPEA: acetonitrile
                                          with 0.05% ascorbic acid.
Cayman Chemical Company................  Phytocannabinoid Acids Mixture   Glass ampule: 0.5 mL.....     2/3/2021
                                          7 (CRM) 500 [micro]g/mL 0.5 mL
                                          in acetonitrile.
Cayman Chemical Company................  Psilocin (CRM) 1 mg/mL in        Glass ampule: 1.0 mL.....    2/24/2021
                                          Acetonitrile.
Cayman Chemical Company................  Psilocin (CRM) 100 [micro]g/mL   Glass ampule: 0.5 mL.....    2/24/2021
                                          in Acetonitrile.
Cayman Chemical Company................  Psilocin-d10 (CRM) 1 mg/mL in    Glass ampule: 1.0 mL.....    2/24/2021
                                          Acetonitrile.
Cayman Chemical Company................  Psilocin-d10 (CRM) 100 [micro]g/ Glass ampule: 1.0 mL.....    2/24/2021
                                          mL in Acetonitrile.
Cayman Chemical Company................  Psilocin-d4 (CRM) 1 mg/mL in     Glass ampule: 1.0 mL.....    2/24/2021
                                          Acetonitrile.
Cayman Chemical Company................  Psilocin-d4 (CRM) 100 [micro]g/  Glass ampule: 1.0 mL.....    2/24/2021
                                          mL in Acetonitrile.
Cayman Chemical Company................  Psilocybin (CRM) 1 mg/mL in 1:1  Glass ampule: 1.0 mL.....    2/24/2021
                                          Acetonitrile:H2O.
Cayman Chemical Company................  Psilocybin (CRM) 100 [micro]g/   Glass ampule: 0.5 mL.....    2/24/2021
                                          mL in 1:1 Acetonitrile:H2O.
Cayman Chemical Company................  Psilocybin-d10 (CRM) 1 mg/mL in  Glass ampule: 1.0 mL.....    2/24/2021
                                          1:1 Acetonitrile:H2O.
Cayman Chemical Company................  Psilocybin-d10 (CRM) 100         Glass ampule: 1.0 mL.....    2/24/2021
                                          [micro]g/mL in 1:1
                                          Acetonitrile:H2O.
Cayman Chemical Company................  Psilocybin-d4 (CRM) 1 mg/mL in   Glass ampule: 0.5 mL.....    2/24/2021
                                          1:1 Acetonitrile:H2O.
Cayman Chemical Company................  Psilocybin-d4 (CRM) 100          Glass ampule: 0.5 mL.....    2/24/2021
                                          [micro]g/mL in 1:1
                                          Acetonitrile:H2O.
Cayman Chemical Company................  U-47700 (CRM) 1 mg/mL, 1 mL in   Glass ampule: 1 mL.......    2/23/2021
                                          methanol.
Cayman Chemical Company................  U-47700 (CRM) 100 [micro]g/mL,   Glass ampule: 1 mL.......    2/23/2021
                                          1 mL in methanol.
Cayman Chemical Company................  U-47700-d6 (CRM) 1 mg/mL, 1 mL   Glass ampule: 1 mL.......    2/23/2021
                                          in methanol.
Cayman Chemical Company................  U-47700-d6 (CRM) 100 [micro]g/   Glass ampule: 1 mL.......    2/23/2021
                                          mL, 1 mL in methanol.
Cerilliant Corporation.................  (-)-delta8-THC-D3..............  Glass ampule: 1 mL.......    1/26/2021
Cerilliant Corporation.................  4-Methyl-alpha-                  Glass ampule: 1 mL.......     3/4/2021
                                          pyrrolidinobutiophenone HCl
                                          (MPBP HCl) (1.0 mg/mL).
Cerilliant Corporation.................  Tetrahydrocannabivarin-D5 (THCV- Glass ampule: 1 mL.......    1/26/2021
                                          D5).
Cerilliant Corporation.................  Tetrahydrocannabivarinic acid-   Glass ampule: 1 mL.......    1/26/2021
                                          D5 (THCVA-D5).
Immunalysis Corporation................  AMP/6-AM Oral Fluid Calibrator   Amber vial: 10 mL........    2/10/2021
                                          1.
Immunalysis Corporation................  AMP/6-AM Oral Fluid Calibrator   Amber vial: 10 mL........    2/10/2021
                                          2.
Immunalysis Corporation................  AMP/6-AM Oral Fluid Calibrator   Amber vial: 10 mL........    2/10/2021
                                          3.
Immunalysis Corporation................  AMP/6-AM Oral Fluid Calibrator   Amber vial: 10 mL........    2/10/2021
                                          4.
Immunalysis Corporation................  AMP/6-AM Oral Fluid Set........  Kit: 2 vials, 10 mL each.    2/10/2021
LGC--Dr. Ehrenstorfer..................  Cannabinoids Acid/Neutrals       1 kit: 2 vials x 0.4 mL..    3/19/2021
                                          Mixture 202 Kit 250 [mu]g/mL
                                          in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Acid/Neutrals       1 kit: 2 vials x 0.4 mL..    3/19/2021
                                          Mixture 203 Kit 500 [mu]g/mL
                                          in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Acid/Neutrals       1 kit: 2 vials x 0.4 mL..    3/19/2021
                                          Mixture 204 Kit 1000 [mu]g/mL
                                          in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Acid/Neutrals       1 kit: 2 vials x 0.4 mL..    3/19/2021
                                          Mixture 205 Kit 250 [mu]g/mL
                                          in Acetonitrile.

[[Page 38768]]

 
LGC--Dr. Ehrenstorfer..................  Cannabinoids Acid/Neutrals       1 kit: 2 vials x 0.4 mL..    3/19/2021
                                          Mixture 206 Kit 500 [mu]g/mL
                                          in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Acid/Neutrals       1 kit: 2 vials x 0.4 mL..    3/19/2021
                                          Mixture 207 Kit 1000 [mu]g/mL
                                          in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Acid/Neutrals       1 kit: 2 vials x 0.4 mL..    3/19/2021
                                          Mixture 214 Kit 250 [mu]g/mL
                                          in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Acid/Neutrals       1 Kit: 2 vials x 0.4 mL..    10/9/2020
                                          Mixture 214 Kit 250 [mu]g/mL
                                          in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Acid/Neutrals       1 kit: 2 vials x 0.4 mL..    3/19/2021
                                          Mixture 215 Kit 500 [mu]g/mL
                                          in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Acid/Neutrals       1 Kit: 2 vials x 0.4 mL..    10/9/2020
                                          Mixture 215 Kit 500 [mu]g/mL
                                          in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Acid/Neutrals       1 kit: 2 vials x 0.4 mL..    3/19/2021
                                          Mixture 216 Kit 1000 [mu]g/mL
                                          in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Acid/Neutrals       1 Kit: 2 vials x 0.4 mL..    10/9/2020
                                          Mixture 216 Kit 1000 [mu]g/mL
                                          in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Acid/Neutrals       1 kit: 2 vials x 0.4 mL..    3/19/2021
                                          Mixture 250 Kit 1000 [mu]g/mL
                                          in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Acid/Neutrals       1 Kit: 2 vials x 0.4 mL..    10/9/2020
                                          Mixture 250 Kit 1000 [mu]g/mL
                                          in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Acids Mixture 184   Amber ampule: 0.4 mL.....    3/19/2021
                                          1000 [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Acids Mixture 185   Amber ampule: 0.4 mL.....    3/19/2021
                                          500 [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Acids Mixture 186   Amber ampule: 0.4 mL.....    3/19/2021
                                          250 [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Acids Mixture 194   Amber ampule: 0.4 mL.....    3/19/2021
                                          250 [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Acids Mixture 195   Amber ampule: 0.4 mL.....    3/19/2021
                                          500 [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Acids Mixture 200   Amber ampule: 0.4 mL.....    3/19/2021
                                          1000 [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Acids Mixture 210   Amber ampule: 0.4 mL.....    3/19/2021
                                          250 [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Acids Mixture 210   Amber ampule: 0.4 mL.....    10/9/2020
                                          250 [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Acids Mixture 211   Amber ampule: 0.4 mL.....    3/19/2021
                                          500 [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Acids Mixture 211   Amber ampule: 0.4 mL.....    10/9/2020
                                          500 [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Acids Mixture 212   Amber ampule: 0.4 mL.....    3/19/2021
                                          1000 [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Acids Mixture 212   Amber ampule: 0.4 mL.....    10/9/2020
                                          1000 [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Mixture 187 100     Amber ampule: 0.4 mL.....    3/19/2021
                                          [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Mixture 188 500     Amber ampule: 0.4 mL.....    3/19/2021
                                          [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Mixture 189 1000    Amber ampule: 0.4 mL.....    3/19/2021
                                          [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Mixture 190 50      Amber ampule: 0.4 mL.....    3/19/2021
                                          [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Mixture 191 100     Amber ampule: 0.4 mL.....    3/19/2021
                                          [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Mixture 192 500     Amber ampule: 0.4 mL.....    3/19/2021
                                          [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Mixture 193 1000    Amber ampule: 0.4 mL.....    3/19/2021
                                          [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Mixture 197 500     Amber ampule: 0.4 mL.....    3/19/2021
                                          [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Mixture 198 500     Amber ampule: 0.4 mL.....    3/19/2021
                                          [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Mixture 213 500     Amber ampule: 0.4 mL.....    3/19/2021
                                          [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Mixture 254 250     Amber ampule: 0.4 mL.....    3/19/2021
                                          [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Mixture 254 250     Amber ampule: 0.4 mL.....    10/9/2020
                                          [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Mixture 255 500     Amber ampule: 0.4 mL.....    3/19/2021
                                          [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Mixture 255 500     Amber ampule: 0.4 mL.....    10/9/2020
                                          [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Mixture 256 250     Amber ampule: 0.4 mL.....    3/19/2021
                                          [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Mixture 256 250     Amber ampule: 0.4 mL.....    3/10/2021
                                          [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Mixture 257 500     Amber ampule: 0.4 mL.....    3/19/2021
                                          [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Mixture 257 500     Amber ampule: 0.4 mL.....    3/10/2021
                                          [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Mixture 258 Kit     1 kit: 2 vials x 0.4 mL..    3/31/2021
                                          250 [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Mixture 258 Kit     1 Kit: 2 vials x 0.4 mL..    3/10/2021
                                          250 [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Mixture 259 Kit     1 kit: 2 vials x 0.4 mL..    3/19/2021
                                          500 [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Cannabinoids Mixture 259 Kit     1 Kit: 2 vials x 0.4 mL..    3/10/2021
                                          500 [mu]g/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  Custom [Delta]9-                 Amber ampule: 1 mL.......    1/19/2021
                                          Tetrahydrocannabivarin (THCV)
                                          1000 ug/mL in Acetonitrile.
LGC--Dr. Ehrenstorfer..................  [Delta]9-                        Amber ampule: 1 mL.......    3/10/2021
                                          Tetrahydrocannabivarinic acid
                                          (THCVA) 100 ug/mL in
                                          Acetonitrile.
o2si smart solutions...................  Chloral Hydrate 1000 [micro]g/   Amber ampule: 1 mL.......    3/24/2021
                                          mL in methanol.
o2si smart solutions...................  Custom Pharmaceutical Mixture    Amber ampule: 300             3/1/2021
                                          CCV 16-0260, 10.0 [micro]g/mL,   [micro]L.
                                          300 [micro]L with a 2 mL
                                          silanized vial (ISO17034).
o2si smart solutions...................  Custom Pharmaceutical Mixture    Amber ampule: 300             3/1/2021
                                          ICV (second source), 16-0260,    [micro]L.
                                          10.0 [micro]g/mL, 300 [micro]L
                                          with a 2 mL silanized vial
                                          (ISO17034).
o2si smart solutions...................  Custom Pharmaceutical Mixture    Amber ampule: 300             3/1/2021
                                          Level #1, 16-0260, 0.3           [micro]L.
                                          [micro]g/mL, 300 [micro]L with
                                          a 2 mL silanized vial
                                          (ISO17034).
o2si smart solutions...................  Custom Pharmaceutical Mixture    Amber ampule: 300             3/1/2021
                                          Level #2, 16-0260, 1.0           [micro]L.
                                          [micro]g/mL, 300 [micro]L with
                                          a 2 mL silanized vial
                                          (ISO17034).
o2si smart solutions...................  Custom Pharmaceutical Mixture    Amber ampule: 300             3/1/2021
                                          Level #3, 16-0260, 5.0           [micro]L.
                                          [micro]g/mL, 300 [micro]L with
                                          a 2 mL silanized vial
                                          (ISO17034).
o2si smart solutions...................  Custom Pharmaceutical Mixture    Amber ampule: 300             3/1/2021
                                          Level #4, 16-0260, 10.0          [micro]L.
                                          [micro]g/mL, 300 [micro]L with
                                          a 2 mL silanized vial
                                          (ISO17034).
o2si smart solutions...................  Custom Pharmaceutical Mixture    Amber ampule: 300             3/1/2021
                                          Level #5, 16-0260, 25.0          [micro]L.
                                          [micro]g/mL, 300 [micro]L with
                                          a 2 mL silanized vial
                                          (ISO17034).
o2si smart solutions...................  Custom Pharmaceutical Mixture    Amber ampule: 300             3/1/2021
                                          Level #6, 16-0260, 50.0          [micro]L.
                                          [micro]g/mL, 300 [micro]L with
                                          a 2 mL silanized vial
                                          (ISO17034).
o2si smart solutions...................  Custom Pharmaceutical Mixture    Amber ampule: 300             3/1/2021
                                          Level #7, 16-0260, 100.0         [micro]L.
                                          [micro]g/mL, 300 [micro]L with
                                          a 2 mL silanized vial
                                          (ISO17034).
o2si smart solutions...................  Custom Pharmaceutical Mixture    Amber ampule: 300             3/1/2021
                                          Level #8, 16-0260, 250.0         [micro]L.
                                          [micro]g/mL, 300 [micro]L with
                                          a 2 mL silanized vial
                                          (ISO17034).
o2si smart solutions...................  Custom Pharmaceutical Mixture    1 kit; 26 amber ampules x     3/1/2021
                                          Calibration Kit 16-0260, (2 x    300 [micro]L.
                                          G34-140260-98).
o2si smart solutions...................  Custom Pharmaceutical Mixture    1 pack; 13 amber ampules      3/1/2021
                                          Calibration Pack 16-0260, 13 x   x 300 [micro]L.
                                          1 ml.
o2si smart solutions...................  Custom Pharmaceutical Mixture    Amber ampule: 1 mL.......     3/1/2021
                                          LCS, 16-0260, 10.0 ug/mL, 1 mL
                                          with a 2 ml Silanized Vial
                                          (ISO17034).
Research Triangle Institute............  0584, 7232, 6089, 8785, 7227,    HDPE tubes: 5 mL.........    3/11/2021
                                          8588, 7541, 4336, 1817, 0737,
                                          5340, 2985, 8470, 3501, 7362,
                                          6850, 5497, 4097, 2479, 1536,
                                          7431, 9541, 1585, 8534, 2113,
                                          9789, 2482, 1013, 1483, 8092,
                                          6365, 2209, 5434, 4035, 9222,
                                          9674, 5622, 3806, 1798, 9820.
Research Triangle Institute............  3370, 1411, 5883, 5713, 8800,    HDPE tubes: 5 mL.........    3/11/2021
                                          3630, 8683, 4541, 8161, 0359,
                                          9704, 2184, 0341, 2901, 0790,
                                          6548, 3466, 0352, 5288, 8594,
                                          0279, 8762, 3687, 2819, 8743,
                                          7197, 5064, 0199, 1609, 8643,
                                          6467, 2245, 0706, 0147, 6876,
                                          3732, 9314, 1059, 8245, 8685.

[[Page 38769]]

 
Research Triangle Institute............  4118, 3472, 9120, 3742, 9323,    HDPE tubes: 5 mL.........    3/11/2021
                                          4475, 5116, 7455, 3780, 9052,
                                          4910, 2630, 6141, 9351, 5220,
                                          2730, 6408, 3560, 4063, 0427,
                                          0669, 8350, 9163, 6359, 0113,
                                          1893, 4552, 2951, 1357, 8372,
                                          9203, 3150, 9587, 9290, 4399,
                                          2454, 2468, 7560, 6645, 8756.
Research Triangle Institute............  4761, 2869, 4267, 9207, 1568,    HDPE tubes: 5 mL.........    3/11/2021
                                          8723, 7042, 6810, 0605, 7181,
                                          8624, 0015, 5050, 7046, 3626,
                                          7515, 9023, 8821, 6767, 0861,
                                          0689, 5934, 2105, 2006, 1040,
                                          5645, 2749, 7908, 9154, 8450,
                                          5251, 6608, 3152, 9027, 2731,
                                          7530, 1329, 0320, 5833, 7580.
Research Triangle Institute............  4946, 2135, 7589, 456, 2617,     HDPE tubes: 5 mL.........    3/11/2021
                                          2224, 5066, 4134, 9514, 0206,
                                          2691, 2807, 1571, 2201, 0943,
                                          6995, 1299, 3729, 9561, 2552,
                                          1248, 7138, 1634, 0813, 6352,
                                          3567, 2017, 6701, 6915, 4448,
                                          1967, 3179, 2480, 5144, 8826,
                                          5515, 0949, 6109, 4040, 8632.
Research Triangle Institute............  6673, 1920, 9080, 9040, 1769,    HDPE tubes: 5 mL.........    3/11/2021
                                          9824, 8015, 4813, 1535, 4285,
                                          5824, 7430, 3338, 2989, 2743,
                                          1537, 6009, 4808, 0243, 7097,
                                          5533, 6638, 3414, 8238, 2573,
                                          6806, 3959, 7896, 3448, 5652,
                                          5273, 1341, 1063, 6664, 9471,
                                          7136, 3571, 8916, 8617, 8946.
Research Triangle Institute............  7155, 9763, 5721, 5161, 0009,    HDPE tubes: 5 mL.........    3/11/2021
                                          8118, 7420, 0527, 4415, 6892,
                                          6896, 8988, 6477, 9903, 6688,
                                          0292, 9380, 4579, 9601, 7337,
                                          1518, 2189, 8886, 8880, 6963,
                                          9446, 7721, 9988, 7688, 2525,
                                          4017, 6826, 3426, 4128, 6270,
                                          4207, 0646, 5741, 6086, 0528.
Research Triangle Institute............  7938, 8287, 2990, 7693, 6858,    HDPE tubes: 5 mL.........    3/11/2021
                                          5995, 1929, 3740, 4461, 0196,
                                          4271, 9853, 5024, 6378, 3409,
                                          2702, 7629, 6194, 4553, 2871,
                                          0203, 4812, 7073, 0834, 2732,
                                          1841, 9545, 5063, 5062, 6234,
                                          0210, 9740, 9472, 9938, 5122,
                                          8677, 3537, 5198, 5977, 8203.
Research Triangle Institute............  8497, 8384, 3406, 0324, 6930,    HDPE tubes: 5 mL.........    3/11/2021
                                          3165, 1564, 8858, 4968, 8840,
                                          7836, 9412, 9009, 0109, 0695,
                                          0923, 0912, 3228, 6855, 5103,
                                          8580, 4499, 8347, 7831, 8420,
                                          2875, 6778, 6680, 9098, 1987,
                                          6813, 6572, 9943, 6165, 0958,
                                          5884, 1843, 2991, 3191, 1151.
Research Triangle Institute............  9493, 8564, 6768, 1670, 2733,    HDPE tubes: 5 mL.........    3/11/2021
                                          0560, 7822, 7495, 1290, 4534,
                                          6583, 3937, 6596, 2599, 9164,
                                          5702, 8328, 9643, 5747, 1923,
                                          0976, 3416, 1445, 3834, 3069,
                                          7609, 6580, 3945, 1726, 2891,
                                          4325, 8970, 7248, 1981, 3906,
                                          0989, 3648, 7769, 4122, 9050.
Restek Corporation.....................  Cannabinoids Acids 7 Standard..  Glass ampule: 1.3 mL.....    3/31/2021
UTAK Laboratories, Inc.................  AED II MR Serum Control........  Kit: 5 bottles, 5 mL each   11/20/2020
UTAK Laboratories, Inc.................  Amphetamines Panel Level 1       Kit: 5 bottles, 5 mL each   11/20/2020
                                          Urine Control.
UTAK Laboratories, Inc.................  Amphetamines Panel Level 2       Kit: 5 bottles, 5 mL each   11/20/2020
                                          Urine Control.
UTAK Laboratories, Inc.................  Benzodiazepines Hydrolysis QC    Kit: 5 bottles, 3 mL each   11/20/2020
                                          Urine Control.
UTAK Laboratories, Inc.................  Benzodiazepines Plus 100 ng/mL   Kit: 5 bottles, 5 mL each   11/20/2020
                                          Urine Control.
UTAK Laboratories, Inc.................  Benzodiazepines Plus 100 ng/mL   Kit: 5 bottles, 5 mL each   11/20/2020
                                          Whole Blood Control.
UTAK Laboratories, Inc.................  Benzodiazepines Plus 400 ng/mL   Kit: 5 bottles, 5 mL each   11/20/2020
                                          Urine Control.
UTAK Laboratories, Inc.................  DAU IA 1 Urine Control.........  Kit: 4 bottles, 10 mL       11/20/2020
                                                                           each.
UTAK Laboratories, Inc.................  DAU IA 2 Urine Control.........  Kit: 4 bottles, 10 mL       11/20/2020
                                                                           each.
UTAK Laboratories, Inc.................  DAU IA 3 Urine Control.........  Kit: 4 bottles, 10 mL       11/20/2020
                                                                           each.
UTAK Laboratories, Inc.................  DAU IA 4 Urine Control.........  Kit: 4 bottles, 10 mL       11/20/2020
                                                                           each.
UTAK Laboratories, Inc.................  DAU IA 5 Urine Control.........  Kit: 4 bottles, 10 mL       11/20/2020
                                                                           each.
UTAK Laboratories, Inc.................  DHEA Plus High Serum Control...  Kit: 5 bottles, 3 mL each   11/20/2020
UTAK Laboratories, Inc.................  DHEA Plus Low Serum Control....  Kit: 5 bottles, 3 mL each   11/20/2020
UTAK Laboratories, Inc.................  Drugs of Abuse 200% Cutoff SMX   Kit: 5 bottles, 3 mL each   11/20/2020
                                          Oral Fluid Control.
UTAK Laboratories, Inc.................  Drugs of Abuse 50% Cutoff SMX    Kit: 5 bottles, 3 mL each   11/20/2020
                                          Oral Fluid Control.
UTAK Laboratories, Inc.................  Drugs of Abuse Cutoff SMX Oral   Kit: 5 bottles, 3 mL each   11/20/2020
                                          Fluid Control.
UTAK Laboratories, Inc.................  Drugs of Abuse Level 2 Whole     Kit: 5 bottles, 5 mL each   11/20/2020
                                          Blood Control.
UTAK Laboratories, Inc.................  Miscellaneous Panel Level 1      Kit: 5 bottles, 5 mL each   11/20/2020
                                          Urine Control.
UTAK Laboratories, Inc.................  Miscellaneous Panel Level 2      Kit: 5 bottles, 5 mL each   11/20/2020
                                          Urine Control.
UTAK Laboratories, Inc.................  Opiates Hydrolysis QC Urine      Kit: 5 bottles, 3 mL each   11/20/2020
                                          Control.
UTAK Laboratories, Inc.................  Pentobarbital Serum Control....  Kit: 5 bottles, 5 mL each   11/20/2020
UTAK Laboratories, Inc.................  STABBS Negative Serum Control..  Kit: 5 bottles, 5 mL each   11/20/2020
UTAK Laboratories, Inc.................  STABBS Positive Serum Control..  Kit: 5 bottles, 5 mL each   11/20/2020
UTAK Laboratories, Inc.................  Steroids Level 1 SMX Serum       Kit: 5 bottles, 3 mL each   11/20/2020
                                          Control.
UTAK Laboratories, Inc.................  Steroids Level 2 SMX Serum       Kit: 5 bottles, 3 mL each   11/20/2020
                                          Control.
UTAK Laboratories, Inc.................  Steroids Level 3 SMX Serum       Kit: 5 bottles, 3 mL each   11/20/2020
                                          Control.
UTAK Laboratories, Inc.................  Steroids Level 4 SMX Serum       Kit: 5 bottles, 3 mL each   11/20/2020
                                          Control.
UTAK Laboratories, Inc.................  Tapentadol Hydrolysis QC Urine   Kit: 5 bottles, 3 mL each   11/20/2020
                                          Control.
UTAK Laboratories, Inc.................  Urine Drug Screen Urine Control  Kit: 5 bottles, 10 mL       11/20/2020
                                                                           each.
UTAK Laboratories, Inc.................  Z Drugs Plus Level 1 Urine       Kit: 5 bottles, 3 mL each   11/20/2020
                                          Control.
UTAK Laboratories, Inc.................  Z Drugs Plus Level 2 Urine       Kit: 5 bottles, 3 mL each   11/20/2020
                                          Control.
Xvivo Perfusion........................  Supplemented XVIVO Heart         Glass vial: 10 mL........    9/11/2020
                                          Solution (SXHS).
Xvivo Perfusion........................  XVIVO Heart Perfusion System     Kit: Heart Box,              9/11/2020
                                          (XHPS).                          Disposable, Supplemented
                                                                           Soln.
----------------------------------------------------------------------------------------------------------------

    The Assistant Administrator has found that each of the compounds, 
mixtures, and preparations described in Chart II below is not 
consistent with the criteria stated in 21 U.S.C. 811(g)(3)(B) and in 21 
CFR 1308.23. Accordingly, the Assistant Administrator has determined 
that the chemical preparations or mixtures generally described in Chart 
II below and specifically described in the application materials 
received by DEA, are not exempt from application of any part of the CSA 
or from application of any part of the CFR, with regard to the 
requested exemption pursuant to 21 CFR 1308.23, as of the date that was 
provided in the determination letters to the individual requesters.

[[Page 38770]]



                                                    Chart II
----------------------------------------------------------------------------------------------------------------
                                                                                                     Application
                Supplier                           Product name                      Form                date
----------------------------------------------------------------------------------------------------------------
Cambridge Isotopes Laboratories, Inc...  Delta-9-tetrahydrocannabinol     Glass ampule: 5 mg.......    2/19/2021
                                          (THC) unlabeled (Chemical
                                          Purity 95%), 5 mg.
Cambridge Isotopes Laboratories, Inc...  Delta-9-tetrahydrocannabinol     Glass ampule: 0.5 mg.....    2/19/2021
                                          (THC) unlabeled (Chemical
                                          Purity 95%), 0.5 mg.
Cambridge Isotopes Laboratories, Inc...  Delta-9-tetrahydrocannabinol     Glass ampule: 1 mg.......    2/19/2021
                                          (THC) unlabeled (Chemical
                                          Purity 95%), 1 mg.
Cambridge Isotopes Laboratories, Inc...  Delta-9-tetrahydrocannabinol     Glass ampule: 10 mg......    2/19/2021
                                          (THC) unlabeled (Chemical
                                          Purity 95%), 10 mg.
Cambridge Isotopes Laboratories, Inc...  Delta-9-Trans-                   Glass ampule: 5 mg.......    2/19/2021
                                          tetrahydrocannabinol (THC)
                                          (Methyl-D3, 98%), 5 mg.
Cambridge Isotopes Laboratories, Inc...  Delta-9-Trans-                   Glass ampule: 0.5 mg.....    2/19/2021
                                          tetrahydrocannabinol (THC)
                                          (Methyl-D3, 98%), 0.5 mg.
Cambridge Isotopes Laboratories, Inc...  Delta-9-Trans-                   Glass ampule: 1 mg.......    2/19/2021
                                          tetrahydrocannabinol (THC)
                                          (Methyl-D3, 98%), 1 mg.
Cambridge Isotopes Laboratories, Inc...  Delta-9-Trans-                   Glass ampule: 10 mg......    2/19/2021
                                          tetrahydrocannabinol (THC)
                                          (Methyl-D3, 98%), 10 mg.
Cayman Chemical Company................  Clonazepam (CRM) 1 mg/mL, 1 mL   Glass ampule: 1 mL.......    2/23/2021
                                          in acetonitrile.
LGC--Dr. Ehrenstorher..................  [Delta]9-Tetrahydrocannabivarin  Boston Round, Amber          1/19/2021
                                          10,000 mg/L Parent stock in      glass: 14 mL.
                                          Methanol--NOT FOR SALE.
LGC--Dr. Ehrenstorfer..................  Delta-9-THC 10000 [mu]g/mL in    Amber ampule: 2 mL.......    2/16/2021
                                          Methanol.
----------------------------------------------------------------------------------------------------------------

Opportunity for Comment

    Pursuant to 21 CFR 1308.23(e), any interested person may submit 
written comments on or objections to any chemical preparation in this 
order that has been approved or denied as exempt. If any comments or 
objections raise significant issues regarding any finding of fact or 
conclusion of law upon which this order is based, the Assistant 
Administrator will immediately suspend the effectiveness of any 
applicable part of this order until he may reconsider the application 
in light of the comments and objections filed. Thereafter, the 
Assistant Administrator shall reinstate, revoke, or amend his original 
order as he determines appropriate.

Approved Exempt Chemical Preparations Are Posted on the DEA's Website

    A list of all current exemptions, including those listed in this 
order, is available on the DEA's website at https://www.DEAdiversion.usdoj.gov/schedules/exempt/exempt_chemlist.pdf. The 
dates of applications of all current exemptions are posted for easy 
reference.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-15024 Filed 7-21-21; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.